cirse 2013

Transcription

cirse 2013

September 14-18
Barcelona, Spain
CIRSE 2013
THE WAVE OF
INNOVATION
PROGRAMME
REGISTRATION
TRAVEL
Cardiovascular and Interventional Radiological Society of Europe
C RSE
28th Annual Meeting and
Postgraduate Course
Contents
General Information
2
4
6
15
19
53
55
56
57
Committees / Welcome Address
Excellence in Interventional Radiology
Dignitaries
CIRSE meets Singapore
Exhibitors
General Information
Registration
Accommodation
City Map
Scientific Programme
12
16
18
22
24
28
30
31
46
Preliminary Faculty
Main Themes
Session Types
Foundation Courses
Hot Topic Symposia
Evidence Forums
Foldout Timetable
Radiographer Programme
Programme
Hands-on Workshops
Facts & Figures CIRSE 2012:
The Second Announcement CIRSE 2013
In case of any enquiries or comments,
please contact us at [email protected]
© Cardiovascular and Interventional
Radiological Society of Europe / 2013
Graphic Design: LOOP.ENTERPRISES media EU
www.loop-enterprises.com
Cover: Architectural detail of Casa Milà (1906-1910),
Barcelona, Spain / Architect: Antoni Gaudi (1852-1926)
Photo © Dreamstime
P. 48: Photo © AlexRaths
Print: Druckerei Janetschek GmbH
Heidenreichstein / Austria
6,173 Participants
85 Countries
1,230 Abstracts
250 Hours of Education
115 Exhibitors
5,600 m² of Technical Exhibition
www.cirse.org
2
Committees / Welcome Address
CIRSE Committees
Executive Committee
Local Host Committee
Michael J. Lee (IE), President
Anna-Maria Belli (UK), Vice President
Mario Bezzi (IT)
Elias Brountzos (GR)
Fabrizio Fanelli (IT)
Patrick Haage (DE)
Klaus A. Hausegger (AT)
Riccardo Lencioni (IT)
Jose J. Martínez Rodrigo (ES)
Robert A. Morgan (UK)
Jan H. Peregrin (CZ)
Philippe L. Pereira (DE)
Dimitrios K. Tsetis (GR)
Dierk Vorwerk (DE)
Daniel Waigl (AT)
José J. Martínez Rodrigo (Valencia), Co-Chairman
José J. Muñoz Ruiz-Canela (Málaga), Co-Chairman
Anna Alguersuari (Sabadell)
Roger Barranco Pons (Barcelona)
Marta Barrufet (Barcelona)
Javier Blazquez Sanchez (Madrid)
Marta Burrel (Barcelona)
Iratxe Díez Miranda (Barcelona)
Joan F. Falco-Fages (Sabadell)
Fernando M. Gómez (Valencia)
Elena Lonjedo (Valencia)
Teresa Moreno Sanchez (Huelva)
Joan Perendreu (Sabadell)
Mercedes Pérez Lafuente (Barcelona)
José M. Rodriguez Mesa (Málaga)
Antonio Segarra Medrano (Barcelona)
Scientific Programme Committee
Robert A. Morgan (UK), Chairman
Patrick Haage (DE), Deputy Chairman
Mario Bezzi (IT)
Christoph A. Binkert (CH)
Saruhan Cekirge (TR)
Afshin Gangi (FR)
Klaus A. Hausegger (AT)
Alexis D. Kelekis (GR)
Antonin Krajina (CZ)
Michael J. Lee (IE)
Riccardo Lencioni (IT)
José J. Muñoz Ruiz-Canela (ES)
Olivier Pellerin (FR)
Otto M. van Delden (NL)
C RSE
3
Michael J. Lee
CIRSE President
Robert A. Morgan
Committee Chairman
Patrick Haage
Committee Deputy
Chairman
José J. Martínez
Rodrigo
Co-Chairman
José J. Muñoz RuizCanela
Co-Chairman
Dear Colleagues,
CIRSE is proud of its status as a European and global IR society,
with members coming from all 5 continents. CIRSE’s involvement in many IR projects around the world lays a firm foundation for a strong and dynamic annual meeting. In staging
CIRSE 2013, our intention is to further globalise both faculty
and audience, helping to reaffirm our meeting’s position as a
major platform for Interventional Radiology on a global scale.
CIRSE 2012 proved another great success, and the Scientific
Programme Committee is hard at work to make sure CIRSE 2013
lives up to this standard. Feedback and evaluation forms from
the meeting in Lisbon have been analysed and used to refine
the scientific and educational menu we will be offering
in Barcelona.
With this Second Announcement, we cordially invite you to
make yourself familiar with the educational and scientific programme of CIRSE 2013. You will find new, cutting-edge topics
have been added and more established sessions have been
improved based on your feedback. We hope it meets
your expectations!
Programme highlights include:
Evidence Forums – new sessions devoted to evidence-based
medicine. Forum topics will include the management of SFA
and BTK peripheral vascular disease, as well as HCC and
colorectal metastases.
Hot Topic Symposia – dynamic sessions on two contemporary
topics – interventional oncology in lung cancer and IR stroke
management.
Controversy Sessions – lively debates covering the management of aortic disease, endoleaks, peripheral vascular
interventions and portal hypertension.
Hands-on Workshops – emphasis will, once again, be placed
on the ever-popular Hands-on Workshops and a new session
dedicated to renal denervation will be introduced.
Last year’s congress saw the introduction of two major new
features, the CIRSE digital App and the live stream from the
main auditorium. The App proved a useful tool for congress
attendees and was downloaded over 2,000 times, and over
500 unique users tuned into the live stream. Due to their clear
popularity, both the CIRSE App and the live stream will also
feature at CIRSE 2013.
Abstract submissions have remained high in recent years. For
CIRSE 2013, we have received 1,360 abstracts: an all-time high
and an increase of 20% compared to 2012.
The CIRSE Annual Meeting is now the largest IR congress in
the world, drawing an attendance of over 6,000 delegates
annually. Finding a congress centre that can accommodate
this large number of attendees can, therefore, be a challenge.
Fortunately, the Barcelona International Convention Centre
fulfils all of our space criteria and we are delighted to have
secured it for our congress. Barcelona is also a city that needs
no introduction, providing the ideal infrastructure for large
congresses as well as many other services catering to visitors.
With all this in mind, we cordially invite you to join us for the
28th Annual CIRSE Congress, which will take place in the
cosmopolitan and inspirational city of Barcelona, Spain
from 14-18 September, 2013.
We look forward to seeing you there!
Amazing Interventions – a new and exciting session featuring
presentations on some of IRs most unusual cases by leading
figures in the field.
Annual Meeting and Postgraduate Course
4
CIRSE Gold Medallists
Gruentzig Lecture
2013
2012 2011
2010 2009
2008 2007
2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 2013
2012 2011
2010 2009 2008
2007
2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 J.I. Bilbao
P.R. Mueller
J.A. Reekers
F.S. Keller
J. Lammer
J.E. Abele, B. Cook
A. Adam
B.T. Katzen
J.F. Reidy
J.L. Struyven
C.L. Zollikofer
J.H. Göthlin, J.-J. Merland, E.P. Zeitler
E. Boijsen, F. Olbert, F. Pinet
P. Rossi
A.M. Lunderquist
D.J. Allison
R.W. Günther
CIRSE Distinguished Fellows
2013
2012 2011
2010 2009 2008 2007
2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 J. Spies, B.S. Tan, P.R. Taylor
G.M. Richter, M. Szczerbo-Trojanowska, K.R. Thomson
J.A. Kaufman, L. Machan, A.F. Watkinson
O. Akhan, W.P.T.M. Mali
A.A. Nicholson, A.C. Roberts
K. Mathias, H.P. Rousseau
K.H. Barth, D.A. Kelekis
A. Rosenberger, G. Simonetti
F.S. Keller, A.J. Roche
A. Besim, B. Läubli, P.R. Mueller, R. Yamada
K. Hiramatsu, F. Joffre, H. Uchida
C. L‘Herminé, J.-M. Rius, M.R. Dean
J.-M. Bigot, J. Edgren
J.-C. Gaux, L. Horváth
U. Tylén
A.R. Essinger
J.H. Göthlin, J.L. Struyven
M.J. Amiel, P. Rossi
U. Erikson
D.J. Allison
E.P. Zeitler
I.P. Enge, A.M. Lunderquist, F. Olbert
A. Pinet, F. Pinet
A. Baert, L. Di Guglielmo, G. Van Andel
J.-L.M. Lamarque, R. Passariello
E. Boijsen, C.B.A.J. Puylaert, E. Voegeli
A. Holden
A. Gangi
J.G. Moss
D. Vorwerk
R. Lencioni
C. Becker
J.C. Palmaz
L. Solbiati
A.C. Roberts
E.P.K. Strecker
K.R. Thomson
P.A. Gaines
B.T. Katzen
J.L. Struyven
S. Wallace
R.W. Günther
P. Rossi
J. Rösch
D.J. Allison
E.P. Zeitler
Roesch Lecture
2013
2012 2011
2010 2009 2008
2007
2006 2005 2004 2003 M. Bezzi
D. Pavčnik
M. Szczerbo-Trojanowska
J.I. Bilbao
M.D. Dake
J.A. Kaufman
K. Ivancev
L. Machan
H.P. Rousseau
F.S. Keller
J. Rösch
Award of Excellence and Innovation in IR
2012
A. Bolia, J.A. Reekers
C RSE
The Award of Excellence and
Innovation in IR
Innovative Spirit
On the occasion of CIRSE 2012, the R.W. Guenther Foundation honoured two excellent interventionists
for their innovative work and dedication in establishing a new ground-breaking technique. Initially,
subintimal angioplasty was met with strong criticism and resistance for many years, but today it is
well accepted and has allowed many limbs to be saved from amputation.
Development
Many dedicated physicians have shown this kind of perseverance, hard work and conviction, which
has helped the relatively young medical field of IR to develop into the fully recognised subspecialty
it is today. Without the continuous development and refinement of new devices and techniques by
resourceful interventional radiologists, the ever-expanding range of treatments offered by our
specialty would not have been possible.
Recognition
Innumerable patients are grateful for the wide range of minimally invasive alternatives to open
surgery from which they can now benefit. Furthermore, CIRSE also wishes to honour your dedication
and excellence in IR and present your innovation to the IR community during the opening ceremony
of CIRSE 2013.
Recipients of this distinction will not only be awarded with a certificate of merit
for their contributions to the field, but also a cash prize of € 5,000.
How to apply
Send us your groundbreaking research results, details of a novel technique you developed, or
the cutting-edge equipment you have just patented. Our board of reviewers welcomes all your
innovations and looks forward to the advances they may bring to IR.
R. W. Günther Foundation
We warmly thank the R.W. Günther Foundation for kindly sponsoring the award. The Foundation is
based in Aachen, Germany and aims to promote science and research, especially in the field of
radiological sciences and diagnostic and interventional radiology, as well as to support national
and international co-operation.
Please note that all applications must be submitted with a relevant CV or,
in the case of research groups, a description of the members involved.
All applications must be submitted by June 14, 2013 to [email protected].
For more information, please visit the CIRSE website.
6
Dignitaries
Distinguished Fellow
James B. Spies
Dr. Spies is Professor and Chair in the Department of Radiology
at Georgetown University Hospital in Washington DC. After
attending Georgetown University School of Medicine,
Dr. Spies completed a Radiology Residency at the University of
California, San Francisco and a fellowship at New York University
School of Medicine in Vascular and Interventional Radiology.
He served four years in the United States Air Force. After military service, he was in private practice for several years before
joining the faculty of Georgetown University in 1997, when he
became an associate professor of radiology. Dr. Spies received
his professorship in 2003 and has served as chair of the Depart
ment of Radiology at the Georgetown University School of
Medicine since 2005.
As part of his visiting professorships, Dr. Spies has lectured
at numerous institutions in the USA and abroad, including
Yale University, the University of Pennsylvania, the Vermont
School of Medicine, the University of Texas Medical Center, the
Taiyuan Central Hospital (China) and many more.
Prof. Spies has an active practice in uterine embolization for
fibroids and has performed extensive research on the procedure. He is recognised as an international authority on the
treatment. He has published over 100 scientific studies, has
given more than 250 invited presentations and has co-edited a
text on uterine embolization. He continues to actively research
uterine embolization and outcomes for various fibroid
therapies.
Prof. Spies is a Fellow of the SIR and the ACR and has served
on numerous national committees for both organisations. He
currently serves as Secretary of the Society of Interventional
Radiology. Among his many awards and honours are the
Meritorious Service Award of the United States Air Force and
the Distinguished Service Commission Award of the American
College of Radiology. Prof. Spies has been voted one of
Washington’s and one of America’s best doctors for seven
years in a row.
Prof. Spies has been a reviewer for numerous journals, including the Journal of Vascular and Interventional Radiology,
Human Reproduction, Obstetrics and Gynecology, the Journal
of Women’s Health, the European Journal of Radiology and
many more. For his work as reviewer, he received the Editor’s
Award for Distinguished Editorial Board Service from the
Journal of Vascular and Interventional Radiology and the
Distinguished Reviewer Award from the Journal Obstetrics and
Gynecology, both in 2009.
Prof. Spies is married to Vivian Fraga, a practicing obstetriciangynaecologist, and has two children, Vivian and Ana Cristina.
He enjoys travelling with his family and is an amateur landscape photographer. He also enjoys woodworking and is an
avid college basketball fan, particularly of the Georgetown
Hoyas.
CIRSE Opening Ceremony and Awards
James B. Spies will be awarded on
Saturday, September 14
14:30-16:00
Dignitaries
Peter R. Taylor
Peter Taylor was born in Bishop Auckland, County Durham, in
the north of England. He was a chorister at Durham Cathedral
and continued his schooling at Canterbury where he studied
the piano under Ronald Smith. He was awarded a performers
diploma as an Associate of the Royal College of Music. He studied medicine at Emmanuel College, Cambridge (where he was
also a choral exhibitioner) and at St. Thomas’ Hospital, London.
Peter trained as a vascular surgeon at St. Mary’s Hospital in
Paddington under Averil Mansfield, John Wolfe and Andrew
Nicolaides and was appointed to Guy’s and Lewisham Hospitals
in 1991 and subsequently to Guy’s and St Thomas’ Hospital in
1997. In the early 1990’s Andy Adam was appointed Professor
of Interventional Radiology at Guy’s Hospital and he encouraged Peter’s close collaboration with John Reidy. This fruitful
relationship introduced aortic endovascular procedures into
the clinical repertoire locally. Notable collaborations with early
endovascular pioneers included Claude Miahle, Fred Keller and
Julio Palmaz which placed Guy’s at the forefront of aortic
endovascular intervention in the UK.
Grants from the Charitable Foundation of Guy’s and St Thomas’
Hospital allowed the building of dedicated hybrid endovascular interventional suites. Early work showed the effectiveness
of endovascular thoracic intervention in preventing spinal cord
ischaemia compared to open surgery.
Peter’s main interest continues to be in carotid and aortic intervention, particularly the endovascular treatment of aortic
dissection. He took part in major randomised trials such as the
UK Small Aneurysm Trial, the EVAR trials, the Asymptomatic
Carotid Surgery Trial and the General Anaesthetic versus Local
Anaesthetic trial for carotid endarterectomy. Recent work in
cludes the investigation of patients with aortic dissection by
dynamic magnetic resonance imaging.
Peter has written many peer reviewed papers and book chapters. He has given numerous lectures at national and international meetings and is in demand as a key opinion leader in
vascular intervention. He is co-chairman of the international
Charing Cross Meeting held annually in London and is a regular speaker at the Veith Symposium in New York. Together with
John Reidy he organises the Guy’s Thoracic Masterclass which
is an international meeting concentrating on cutting edge
endovascular thoracic intervention. He is also a referee for
nine major vascular journals.
Peter was awarded the James IV Travelling Scholarship in 1999
and visited Professor Safi at the Memorial Hermann Hospital in
Houston, Professor Glovitski at the Mayo Clinic, Rochester,
Minnesota, and Professors Jim May, John Harris and Geoff White
in Sydney, Australia. He has been a visiting professor to the
Houston Methodist Hospital and Baylor Medical School with
Professor Alan Lumsden, the University of Pittsburgh Medical
Centre with Professor Michel Makaroun and the Royal Prince
Alfred Hospital in Sydney with Professor John Harris. Peter was
president of the Vascular Society of Great Britain and Ireland
in 2008-9. He became Clinical Professor of Vascular Surgery at
King’s College London in 2010 and was made an honorary
fellow of the British Society of Interventional Radiologists in
2010.
Peter lives with his wife Kok-tee, a retired radiologist, whom
he met when they were both medical students in Cambridge.
They have a mutual interest in the piano and classical music,
regularly attending concerts and opera. They enjoy museums,
art galleries and dining in fine restaurants in London and
around the world.
Peter R. Taylor will be awarded on
14:30-16:00
7
8
Dignitaries
Bien Soo Tan
Tan Bien Soo was born and raised in the island state of
Singapore. He received his education at the Anglo-Chinese
School, his father’s alma mater. Bien Soo then enrolled in medical school at the National University of Singapore, graduating
in 1985. He counts meeting and successfully courting his wife,
Soo See, a fellow classmate, as his greatest achievement in
medical school. Both of them then pursued postgraduate
training in diagnostic radiology in Singapore, obtaining the
Fellowship of the Royal College of Radiologists. When they
married in 1989, they had visions of travelling the world
together, attending radiological conferences. This did not
quite materialise. Bien Soo pursued a career in Interventional
Radiology while his wife, being the more sensible and capable
half, developed her interests in ultrasound and breast imaging,
in addition to caring for the couple’s children.
Bien Soo’s initial training in Interventional Radiology was in the
Department of Diagnostic Radiology at the Singapore General
Hospital (SGH), under the tutelage of Dr. Austin Htoo. He then
had the privilege of pursuing a fellowship at Guy’s Hospital in
London, where he trained under Prof. Andy Adam and Dr. John
Reidy. He returned home in 1995, and soon after was appointed Director of Vascular and Interventional Radiology in SGH.
His tenure witnessed rapid expansion of the Interventional
Radiology services in SGH, establishing the centre as the
largest in South East Asia.
Having greatly benefited from his training at Guy’s Hospital,
Bien Soo established a clinical fellowship in Interventional
Radiology at SGH, with the objective of equipping radiologists
in the region with basic and advanced skills in Interventional
Radiology. This ‘hands-on’ fellowship programme has since
flourished and currently 4-6 fellows from across Asia and
beyond are trained annually at SGH.
Bien Soo was the inaugural Chairman of the Cardiovascular and
Interventional Radiology Section of the Singapore Radiological
Society from 2000 to 2002. Having trained in Europe, he has
been a corresponding member of CIRSE since 1996. He was
conferred CIRSE fellowship in the year 2000. He is also a corresponding fellow of SIR. Bien Soo has lectured widely on
Interventional Radiology in the Asia Pacific region, as well as at
the annual CIRSE and SIR meetings. In 2011, he joined the team
of editors at CVIR. He is currently the President-Elect of the Asia
Pacific Society of Cardiovascular and Interventional Radiology
and the organising chairman of the Asia Pacific Conference of
Cardiovascular and Interventional Radiology 2014, which will
be held in Singapore. Bien Soo was appointed Head of the
Department of Diagnostic Radiology in SGH in 2002, a post he
took over from one of his mentors, Dr. Tan Kim Ping, and which
he held until 2010. He was also the President of the Singapore
College of Radiologists from 2009 to 2011.
Bien Soo’s passion for teaching extends beyond Interventional
Radiology. He is also deeply involved in undergraduate and post
graduate training for diagnostic radiology. He has chaired the
national committee for postgraduate diagnostic radiology train
ing in Singapore since 2008. In addition, he is an Associate Pro
fessor in both medical schools in Singapore (the Yong Loo Lin
School of Medicine and the Duke-NUS Graduate Medical School).
Bien Soo’s involvement in research is based on his conviction
that interventional radiologists should play a critical role in
shaping the evidence in the field of minimally invasive therapy.
The team at the Interventional Radiology Centre at SGH has
conducted several investigator-led randomised controlled
trials, studying various aspects of haemodialysis interventions
and critical limb ischaemia therapy.
Beyond the arena of radiology, he has held various appointments
in the Singapore Armed Forces, by virtue of the compulsory national service programme in Singapore. He was the Commanding
Officer of a medical support battalion from 1999 to 2003, an out
standing unit that won the Best Combat Service Support Batta
lion Award for a record-breaking nine years from 1996 to 2004.
Bien Soo and Soo See are the proud parents of four wacky child
ren, Sarah, Deborah, Joanna and Yuancheng, and they have an
even wackier dog called Cleo. They treasure family time toge
ther and love travelling when the opportunity arises. Since his
knees gave way last year, Bien Soo has had to give up running,
and he now enjoys a good swim. He has been a long-suffering
fan of Manchester City Football Club since 1969, and views the
club’s new found wealth and success with some suspicion.
He also enjoys discovering new food haunts on the island of
Singapore, where eating is a favourite past-time, and aspires to
start a food blog when he retires.
Bien Soo Tan will be awarded on
14:30-16:00
Dignitaries
Gold Medallist
José I. Bilbao
José Ignacio “Nacho” Bilbao was born in 1956 in Bilbao and grew
up in the Cantabria region. He studied medicine at the Univer
sit y of Navarra (1973-1979) where he received his doctorate
cum laude in 1988. Following his specialisation in radiology at
the University Clinic of Navarra (CUN), he worked in the hospi
tal’s Radiology Department. In 1991, José Ignacio Bilbao was
made Associate Professor of Radiology and Physical Medicine
at the University of Navarra, and became a Professor in 2007.
From 1998 until 2004, Prof. Bilbao directed the Radiology
Department of the CUN.
From the beginning of his studies, Prof. Bilbao showed great
interest in the surgical specialties. During a 1982 fellowship at
the MD Anderson in Houston, Texas, under the tutorship of
Dr. Sydney Wallace and Dr. Luis Alonso de Santos, Prof. Bilbao
discovered the great therapeutic potential of angiographic
procedures, needles and drainages. With the valuable help of
other specialists of the CUN and after various visits to hospitals
across Spain with Dr. Ricardo Tobio and Dr. Manuel Maynar,
among others, Prof. Bilbao co-established the CUN’s Inter
ventional Radiology Department, which he has headed
ever since.
In 1984, the department started using intra-arterial chemothe
rapy in the treatment of bone tumours and hepatic tumours,
as well as breast and lung neoplasms. After visiting the Univer
sities of Chiva (Dr. Kunio Okuda) and Nara (Dr. Hideo Uchida)
with his colleagues, Prof. Bilbao started using lipiodol and thus
chemoembolization for the treatment of hepatocellular
carcinomas in 1986. Upon meeting Dr. Francis Joffre and
Dr. Hervé Rousseau in 1989, Prof. Bilbao began collaborating
with the renowned experts on various subjects, including TIPS.
After carrying out a comprehensive experimental study, the
team started performing exclusive transjugular access, echographic guidance of portal puncture and the use of autoexpandable endoprostheses. Prof. Bilbao later worked with Joffre
and Rousseau on a study showing the superiority of covered
vs. non-covered prostheses in terms of permeability. During
that time, the team also collaborated with Drs Chigogidze and
Avaliani from the Bakuolev Institute in Moscow on experimental models for extrahepatic porto-cava connections by means
of magnets and specific metal prostheses. In co-operation with
the Department of Animal Histology of the Veterinarian Faculty
of the University of Zaragoza, Prof. Bilbao started studying the
“in vivo” characteristics of various embolizing agents in 2002,
the results of which have provided more insight into the differences in their characteristics and applicability. In 2003, the IR
department also began using radioembolization.
Prof. Bilbao has authored 35 book chapters and co-edited a
book on radioembolization together with Dr. Reiser. Further
more, he has published 155 articles in Spanish and international peer-reviewed journals, achieving an impact factor of
200 and approximately 1,000 citations. Prof. Bilbao edits and
reviews for 10 Spanish and international journals, including
JVIR, for which he is associate editor. He has presented 400 pa
pers at various congresses and has been invited to give
300 lectures at conferences around the globe.
In 1986, Prof. Bilbao co-founded the Spanish Society of
Vascular and Interventional Radiology (SERVEI) which he
headed from 1992 until 1995. He has been an active member
of CIRSE since its beginnings and has attended every one of
its congresses, presenting original material through posters,
oral presentations (awarded in 2001, 2002 and 2004) or invited lectures. Prof. Bilbao has been very active in other areas
of CIRSE, serving as a member of the Clinical Practice Guide
Task Force (1999-2001), as Education Officer (2001-2003), Local
Host Committee Co-Chairman (2004, 2010) and Member of
the Executive Board upon invitation (2006-2009). In 2010 he
was the Josef Roesch Lecturer for CIRSE, speaking on TIPS. The
same year he was awarded the CVIR Editor’s Medal.
Prof. Bilbao is currently President of the European Congress of
Radiology (ECR 2013). Within the European Society of Radiology
(ESR), he has served as a member of the Educational Board
(2002-2008) and has very actively contributed to the ESR’s
e-learning initiatives. He is the Spanish representative in the
POC-UEMS (2002-2005) and the chairman of the ESR’s Subspe
cialty Committee (2005-2008). He actively contributed to the
creation of the ESR, for which he received the Diploma of the
European Association of Radiology in 2007. Prof. Bilbao’s most
outstanding awards have been conferred by the RSNA for his
work on TIPS (1992-1998) as well as by the Dr. J.M. Sánchez
Pérez Foundation and the Rafael Hervada Foundation for his
work on direct vascular connections in 2003.
At a national level, Prof. Bilbao has served as the delegate for
international affairs of the Spanish Society of Medical Radiology
(SERAM) from 2002-2006. Today, he serves as one of the society’s
representatives in the National Commission on Radiodiagnostics.
José I. Bilbao will be awarded on
14:30-16:00
9
10
Dignitaries
Gruentzig Lecturer
Andrew Holden
Andrew Holden was born in Auckland, New Zealand, on
August 22, 1960. He was raised in Wellington as one of seven
children, with three older sisters, two younger sisters and one
brother. Although Andrew did well at school, his real passion
was sport as he represented his school in top rugby and cricket
teams. He was also a national prize winner in public speaking
and debating.
Andrew decided to study medicine at Otago University in
Dunedin – the oldest and most renowned medical school in
New Zealand. After completing his clinical years as a medical
student in Wellington and taking a 12-month break from medicine to travel, Andrew was accepted into the 5-year radiology
training programme at Auckland Hospital. In his final year, he
was appointed chief registrar and won the best research paper
prize for a junior radiologist or registrar at the 1992 RANZCR
Annual Scientific Meeting in Queensland, Australia. The prize
was a week with Professors Ken Thomson and Arina Van Breda
(then president of SIR) doing intervention at the Royal
Melbourne Hospital. This experience confirmed to Andrew
that Interventional Radiology was his career pathway.
In 1994, Andrew travelled to Royal Perth Hospital in Australia
to gain two years of fellowship experience in Interventional
Radiology and body imaging. During that time, the Vascular
Surgery and Interventional Radiology Departments worked
closely to develop an endograft for aneurysm disease which
subsequently became the highly successful Cook Zenith endograft. Andrew was lucky enough to be an integral part of
the team during the first 100 human cases in Perth and was
involved in proctoring other national and international sites as
they used the device.
In 1997, Andrew returned to Auckland Hospital as a staff interventional radiologist and in 2002 he was appointed Director of
Interventional Radiology, a position he still holds today. He
is head radiologist for the NZ Liver Transplant Programme and
co-director of the Auckland Endovascular Service. In 2005, he
was appointed associate professor of radiology at Auckland
University. Andrew is a committee member of IRSA (Interven
tional Society of Australasia) and ARGANZ (Abdominal Radio
logy Society of Australia and New Zealand) as well as an examiner for the RANZCR. He is a member of CIRSE and national
representative for ESGAR.
Andrew has always had an interest in research, particularly related to interventional devices and techniques. He is the author
of over 60 articles in peer-reviewed journals and five book
chapters. His interests include advanced endovascular aneurysm repair techniques, renal and carotid artery intervention,
intervention in critical limb ischaemia and advanced liver imag
ing. Together with his vascular surgical colleague and medical school classmate Andrew Hill, Andrew runs the Vascular
Research Programme at Auckland Hospital, employing 3 fulltime research coordinators. Andrew has been the principal
investigator in 25 “first-in-man” device trials.
Andrew has presented many times at international scientific
meetings, often as part of the invited faculty. He has performed over 50 live interventional cases broadcasts from
Auckland Hospital to overseas sites such as Germany, France,
Hong Kong, USA and Australia. He has proctored interventional cases in China, India, Thailand, Hong Kong, Malaysia and
Australia.
Andrew has been married to his best friend Tracey for 28 years,
getting married when he was 24 and she was only 22. They
met at the university hostel in Dunedin, shared a flat the following year when still “just good friends” and then fell in love
the following year. They have four fantastic children. Sam (26)
is a successful international criminal lawyer, having worked in
The Hague and now in London. He is also a musician, gaining
great success in “The Voice” in Holland in 2012. Tom (22) is in
his fourth year of architecture and is also a talented musician,
Jacob (18) is in his first year of engineering and Grace (13) is in
her first year of secondary school.
Andrew likes to stay fit, loves hiking, climbing and has run
six marathons, the most recent in 2012. He plays golf and
tennis and loves both river and sea fishing. Andrew is very
patriotic and immensely proud of being a Kiwi. He loves his
beautiful country, family and friends.
Andreas Gruentzig Lecture
EVAR for AAA – evolution or revolution?
Sunday, September 15
14:30-15:00
Dignitaries
Roesch Lecturer
Mario Bezzi
A native of Rome, Italy, Prof. Mario Bezzi attended the University
of Rome “Sapienza”, where he graduated summa cum laude
from the School of Medicine in 1982. He entered the Depart
ment of Surgery of the same university and practiced surgery
for one year; this post-graduate training in surgery was instrumental in improving his clinical background and surgical skills.
While involved in the first clinical applications of intraoperative
ultrasound, however, he developed an interest in diagnostic
imaging.
Between 1983 and 1986, he completed his residency in diagnostic radiology at the University of Rome “Sapienza”, followed
by a two-year fellowship in CT-US-MRI at the Department of
Radiology of Thomas Jefferson University and at the University
of Pennsylvania, both in Philadelphia, under the tutorship of
Dr. Barry B. Goldberg and Dr. Herbert Y. Kressel.
In 1988, he started his interventional career in the Division of
Cardiovascular and Interventional Radiology at the Hospital
of the University of Rome. His mentor at that time was Prof.
Plinio Rossi. Many of the procedures in non-vascular radiology
which are now considered routine, such as abscess drainage,
biliary drainage and stenting, dilation of benign biliary strictures, chemoembolization and RF ablation of liver tumours,
were either introduced to Italy or further developed by the
team of interventional radiologists working in this division.
Prof. Bezzi is Aggregate Professor of Radiology at the University
of Rome “Sapienza” and is responsible for the management of
human and technological resources in his department. He is
an enthusiastic teacher and is committed to training the next
generation of radiologists, tutoring both medical students and
residents in imaging and Interventional Radiology.
His clinical practice consists mainly of image-guided therapy
in oncology and his research interests focus primarily on liver
tumours. He has been involved in a number of grant-funded
studies, often as principal investigator. Currently his interest is
centred in MR-guided focused ultrasound, and he is involved
in two European projects on the applications of MRgFUS in
moving organs.
Prof. Bezzi has authored 15 book chapters and edited a book
on biliary tract radiology in collaboration with Prof. Plinio Rossi.
Furthermore, he has published 150 articles in Italian and inter
national peer-reviewed journals, achieving approximately
1,200 citations. Prof. Bezzi reviews for a number of international journals (CVIR, JVIR, European Radiology) and has presented
more than 400 papers at various congresses.
From early in his career, Prof. Bezzi has been involved in the
activities of CIRSE. He was nominated Chairman of the Scientific
Programme Committee for the 1996 Annual Meeting in Madeira,
and subsequently supervised the Scientific Programme of
CIRSE ‘97, ’98 and ‘99. Since then, Prof. Bezzi has been very active within the CIRSE, serving as Chairman of the Standards of
Practice Committee (1999-2003), as organiser of CIRSE 2006 in
Rome, as a member of the Programme Committee (2007-2012),
and as a member of the Executive Committee since 2012.
Currently, he is Editor-in-Chief of ESIRonline, the website
platform that houses all lectures and presentations from
CIRSE events.
Mario Bezzi has been married to his charming wife, Ada, for
more than 25 years and is the proud father of a beautiful
daughter, Costanza. In his free time, he enjoys watersports and
sailing, as well as travelling and contemporary art. He is also a
wine-lover who enjoys wine tastings and visiting vineyards.
Josef Roesch Lecture
High-intensity focused ultrasound: an IR tool for
the future?
Tuesday, September 17
13:00-13:30
11
12
Preliminary Faculty
The Wave of Innovation
Preliminary Faculty
as per printing date – subject to change
Abdel Rehim M.
Abi-Jaoudeh N.
Åkesson M.
Akhan O.
Alexopoulou E.*
Alfke H.*
Al-Kutoubi A.M.
Almeida P.A.M.S.
Amoretti N.
Andersen P.E.*
Andersson T.
Anselmetti G.C.
Arai Y.
Atar E.
Baek J.H.
Bale R.
Barnacle A.M.
Barranco Pons R.
Bartal G.
Basile A.*
Batistaki C.
Belli A.-M.*
Bérczi V.*
Beregi J.-P.
Berkefeld J.
Berlis A.
Bezzi M.*
Bianchi Cardona L.
Bilbao J.I.*
Binkert C.A.*
Boyer L.*
Boyvat F.*
Breen D.J.
Brennan P.
Brountzos E.*
Buecker A.*
Burnes J.P.
Buy X.
Cahill A.M.
Carnevale F.C.
Carrafiello G.*
Castaño C.
Černá M.*
Chapot R.
Chatziioannou A.N.*
Chavan A.
Ciaralli C.
Clark T.W.I.
Clark W.A.
Clifton A.
Cognard C.
Clichy-Paris/FR
Bethesda, MD/US
Malmoe/SE
Ankara/TR
Athens/GR
Lüdenscheid/DE
Beirut/LB
Viseu/PT
Nice/FR
Odense/DK
Stockholm/SE
Turin/IT
Tokyo/JP
Petah Tikva/IL
Seoul/KR
Innsbruck/AT
London/UK
Barcelona/ES
Kfar-Saba/IL
Catania/IT
Athens/GR
London/UK
Budapest/HU
Nîmes/FR
Frankfurt/DE
Augsburg/DE
Rome/IT
Barcelona/ES
Pamplona/ES
Winterthur/CH
Clermont-Ferrand/FR
Ankara/TR
Southampton/UK
Dublin/IE
Athens/GR
Homburg/DE
Clayton, VIC/AU
Bordeaux/FR
Philadelphia, PA/US
São Paulo/BR
Varese/IT
Badalona Barcelona/ES
Olomouc/CZ
Essen/DE
Athens/GR
Oldenburg/DE
Rome/IT
Philadelphia, PA/US
Kogarah, NSW/AU
London/UK
Toulouse/FR
Corona M.
Crocetti L.*
Dake M.D.
Darcy M.
Das M.
de Baère T.*
de Haan M.W.*
De Vries C.
Defreyne L.
Denys A.*
Di Primio M.
Do Y.-S.
Düx M.*
Ellis P.K.*
England A.
Fanelli F.*
Filippiadis D.K.
Fournier-Dujardin L.S.
Funaki B.S.
Funovics M.A.*
Fuster Obregón J.
Fütterer J.J.
Gaines P.A.
Gandini R.
Gangi A.*
García-Pagán J.C.
Garnon J.
Gebauer B.
Gedroyc W.M.
Geschwind J.-F.H.
Gillams A.*
Giménez M.E.
Given M.F.
Glynos M.K.
Goffette P.P.*
Gogna A.
Goh G.S.*
Golzarian J.
González García A.
Grosso M.
Guerini H.
Guimaraes M.
Güven K.
Haage P.*
Hacking N.
Hamady M.S.
Hardman J.
Haskal Z.J.
Haslam P.J.*
Hatzidakis A.*
Hausegger K.A.*
C RSE
Rome/IT
Pisa/IT
Stanford, CA/US
St. Louis, MO/US
Maastricht/NL
Villejuif/FR
Maastricht/NL
Bloemfontein/ZA
Ghent/BE
Lausanne/CH
Paris/FR
Seoul/KR
Frankfurt/DE
Belfast/UK
Liverpool/UK
Rome/IT
Athens/GR
Paris/FR
Chicago, IL/US
Vienna/AT
Barcelona/ES
Nijmegen/NL
Sheffield/UK
Rome/IT
Strasbourg/FR
Barcelona/ES
Strasbourg/FR
Berlin/DE
London/UK
Baltimore, MD/US
London/UK
Buenos Aires/AR
Dublin/IE
Athens/GR
Brussels/BE
Singapore/SG
London/UK
Minneapolis, MN/US
Sevilla/ES
Cuneo/IT
Paris/FR
Charleston, SC/US
İstanbul/TR
Wuppertal/DE
Southampton/UK
London/UK
Bath/UK
Baltimore, MD/US
Newcastle-upon-Tyne/UK
Iraklion/GR
Klagenfurt/AT
Preliminary Faculty
Barcelona 2013
Hechelhammer L.*
Helmberger T.K.*
Henkes H.
Hicks M.E.
Hinchliffe R.J.
Hirota S.
Hoffmann R.-T.
Hohl C.*
Holden A.
Huppert P.E.
Iezzi R.
Irani F.G.
Itkin M.
Jackson J.E.*
Jahnke T.*
Jakobs T.F.
Jargiello T.
Jaschke W.*
Karani J.B.
Karnabatidis D.*
Katoh M.
Katsanos K.N.*
Kaufman J.A.
Keeling A.
Kelekis A.D.*
Kenny L.M.
Kessel D.O.*
Kettenbach J.*
Kichikawa K.
Kim Y.H.
Kobeiter H.
Köcher M.*
Koelemaij M.J.W.
Krajina A.*
Kroencke T.J.*
Krokidis M.*
Kuang M.
Lammer J.*
Lawler L.P.*
Lee M.J.*
Lencioni R.*
Liebig T.
Loffroy R.
Loftus I.
Lohle P.N.M.
Lönn L.*
* EBIR Diploma holders
López-Ben S.
Lozano J.M.
Lyon S.M.
Macdonald S.*
Machan L.
Madureira A.M.
Mahnken A.H.*
Malagari K.*
Maleux G.A.*
Manca A.
Manzi M.
Markus H.S.
Martin D.F.
Martínez de la Cuesta A.
Masala S.
Maskova J.*
Matson M.B.
Matzko M.
McBride K.D.
McEniff N.*
McPherson S.J.*
McWilliams R.G.*
Melchiorre F.
Melzer A.
Minko P.
Monfardini L.
Mueller P.R.
Müller-Hülsbeck S.*
Munneke G.J.
Napoli A.
Narayanan G.
Nicholson A.A.*
Nutting C.W.
Oguzkurt L.*
Orsi F.*
Palussière J.
Panci S.
Park S.
Paulo G.N.
Peetrons P.
Pelage J.-P.
Pellerin O.
Peregrin J.H.*
Pereira P.L.*
Peynircioglu B.
Pfammatter T.*
St. Gallen/CH
Munich/DE
Stuttgart/DE
Houston, TX/US
London/UK
Nishinomiya/JP
Dresden/DE
Siegburg/DE
Auckland/NZ
Darmstadt/DE
Rome/IT
Singapore/SG
Philadelphia, PA/US
London/UK
Neumünster/DE
Munich/DE
Lublin/PL
Innsbruck/AT
London/UK
Patras/GR
Krefeld/DE
London/UK
Portland, OR/US
Dublin/IE
Athens/GR
Brisbane, QLD/AU
Leeds/UK
Bern/CH
Nara/JP
Daegu/KR
Créteil/FR
Olomouc/CZ
Amsterdam/NL
Hradec Králové/CZ
Berlin/DE
London/UK
Guangzhou/CN
Vienna/AT
Dublin/IE
Dublin/IE
Pisa/IT
Köln/DE
Dijon/FR
London/UK
Tilburg/NL
Copenhagen/DK
EB I R
13
Girona/ES
Bogota/CO
Melbourne, VIC/AU
Newcastle-upon-Tyne/UK
Vancouver, BC/CA
Porto/PT
Marburg/DE
Athens/GR
Leuven/BE
Candiolo/IT
Abano Terme/IT
London/UK
Manchester/UK
Pamplona/ES
Rome/IT
Aberdeen/UK
London/UK
Dachau/DE
Dunfermline/UK
Dublin/IE
Leeds/UK
Liverpool/UK
Milan/IT
Dundee/UK
Homburg/DE
Milan/IT
Boston, MA/US
Flensburg/DE
London/UK
Rome/IT
Miami, FL/US
Leeds/UK
Englewood, CO/US
Adana/TR
Milan/IT
Bordeaux/FR
Florence/IT
Daejeon/KR
Coimbra/PT
Brussels/BE
Caen/FR
Paris/FR
Prague/CZ
Heilbronn/DE
Ankara/TR
Zurich/CH
European Board of Interventional Radiology
The European qualification in Interventional Radiology
14
Preliminary Faculty
Piotin M.
Paris/FR
Pisco J.M.
Lisbon/PT
Platts A.D.
London/UK
Pozzi-Mucelli F.
Trieste/IT
Preckel B.
Amsterdam/NL
Pua U.
Singapore/SG
Pulido-Duque J.M.
Las Palmas de Gran Canaria/ES
Punamiya S.
Singapore/SG
Qanadli S.D.
Lausanne/CH
Rand T.*
Vienna/AT
Ray, C.E.
Golden, CO/US
Reekers J.A.*
Amsterdam/NL
Reimer P.*
Karlsruhe/DE
Richter G.M.*
Stuttgart/DE
Rilling W.S.
Milwaukee, WI/US
Roberts A.C.
La Jolla, CA/US
Robertson I.*
Glasgow/UK
Roček M.*
Prague/CZ
Rodière M.
Grenoble/FR
Rose S.C.
San Diego, CA/US
Rosen G.
Tel Aviv/IL
Rousseau H.
Toulouse/FR
Ruffino M.A.
Turin/IT
Ryan A.G.
Waterford City/IE
Ryan M.*
Dublin/IE
Sabharwal T.*
London/UK
Sala Blanch X.
Barcelona/ES
Salem R.
Chicago, IL/US
Sapoval M.R.*
Paris/FR
Schoder M.*
Vienna/AT
Schultze Kool L.J.*
Nijmegen/NL
Schürmann K.*
Dortmund/DE
Sharma S.
Delhi/IN
Shoenfeld R.B.
West Orange, NJ/US
Sibert A.
Clichy/FR
Sierre S.
Buenos Aires/AR
Silkoset R.D.
Østerås/NO
Solbiati L.
Busto Arsizio/IT
Song H.-Y.
Seoul/KR
Soulez G.
Montreal, QC/CA
Spies J.B.
Washington, DC/US
Stracke C.P.
Bonn/DE
Szczerbo-Trojanowska M. Lublin/PL
* EBIR Diploma holders
EB I R
Tacke J.*
Tan B.S.
Tay K.-H.
Taylor P.R.
Tepe G.*
Tesdal I.K.*
Thiounn N.
Thompson M.
Thony F.
Trerotola S.O.
Tsetis D.K.*
Tsoumakidou G.
Turmel-Rodrigues L.*
Tutton S.M.
Uberoi R.*
Urbano J.
Válek V.*
van Delden O.M.*
van den Berg J.C.
van den Bosch M.
van Erkel A.R.
van Lienden K.P.
van Overhagen H.*
van Rijswijk C.S.P.
van Strijen M.J.L.
Vano E.
Vari A.
Veltri A.
Verhoeven E.L.
Vilar J.
Vorwerk D.*
Vos J.A.
Vrachliotis T.-E.G.*
Wagner H.-J.*
Waldenberger P.*
Walser E.M.
Watkinson A.F.*
West D.J.*
Widmark A.
Wilhelm K.E.*
Wolf F.*
Wood B.J.
Passau/DE
Singapore/SG
Singapore/SG
London/UK
Rosenheim/DE
Friedrichshafen/DE
Paris/FR
London/UK
Grenoble/FR
Philadelphia, PA/US
Iraklion/GR
Strasbourg/FR
Tours/FR
Milwaukee, WI/US
Oxford/UK
Madrid/ES
Brno/CZ
Amsterdam/NL
Lugano/CH
Utrecht/NL
Leiden/NL
Amsterdam/NL
The Hague/NL
Leiden/NL
Nieuwegein/NL
Madrid/ES
Rome/IT
Orbassano/IT
Nuremberg/DE
Valencia/ES
Ingolstadt/DE
Nieuwegein/NL
Athens/GR
Berlin/DE
Linz/AT
Galveston, TX/US
Exeter/UK
Stoke-on-Trent/UK
Østerås/NO
Bonn/DE
Vienna/AT
Bethesda, MD/US
Barcelona 2013
CIRSE meets ...
CIRSE meets ...
Singapore
The CardioVascular and Interventional Radiology (CVIR)
Subsection of the Singapore Radiological Society (SRS) was
formed in the year 2000 and currently comprises just over
40 members. Most of our members have undergone IR fellow
ship training in the UK, Australia, USA, Canada and more
recently in France, Italy and Germany. Our public and private
hospitals have state-of-the-art angiographic equipment and
are offering the full spectrum of IR services.
Our subsection members meet monthly to share interesting
cases or mortality/morbidity cases, providing an excellent
chance to learn from each other. We also regularly invite overseas experts to lecture at our monthly meetings. The highlight
of our education calendar is the annual workshop – WIRES
(Workshop in Interventional Radiology Education Singapore).
The workshop is conducted over a weekend with local and
overseas experts sharing their expertise on one or two IR
themes. Concurrent sessions designed for IR nurses and
technicians are also included in the WIRES programme.
Tuesday, September 17, 10:00-11:00
CM 2605 CIRSE meets Singapore
Moderators: M.J. Lee (Dublin/IE),
K.-H. Tay (Singapore/SG)
2605.1 IR management of ultra-large
hepatocellular carcinomas
U. Pua (Singapore/SG)
2605.2 Haemodialysis access interventions –
randomised trials from Singapore
F.G. Irani (Singapore/SG)
2605.3 “Angioplasty first” approach to critical
limb ischaemia
A. Gogna (Singapore/SG)
We look forward to a closer collaboration with CIRSE,
particularly in the areas of IR education, research and
best practices!
Kiang-Hiong Tay
Chairman, CVIR Subsection of the SRS
The CIRSE meets… programme has proved to be an important
platform for establishing and strengthening the relations
between CIRSE and its distinguished Group Members – the
national societies in the field of Interventional Radiology.
Experts from various regions around the world have provided
interesting insights into the current status of Interventional
Radiology as well as the state of specific procedures and
conditions in their home countries.
15
16
Main Themes
How to navigate the scientific
programme in this booklet
The programme is designed to facilitate itinerary planning
allowing delegates to follow one of these themes with little
or no overlap. In this booklet you will find colour codes for
each of the six main themes. Those codes can be found
throughout the whole programme (programme overview,
main theme description, programme in chronological order).
This way you will easily recognise your topics of interest.
Vascular Interventions
Interventional Oncology
The programme for vascular interventions will once again be
one of the most dominant in the 2013 congress, with numerous
Special Sessions devoted to vascular disease. Among the high
lights of the CIRSE 2012 congress in Lisbon were the outcomes
of the latest trials in the management of SFA and BTK peripheral
vascular disease, and these sessions will be repeated under the
new umbrella of Evidence Forums. This new format will be
devoted to trial updates and is a continuation of the increased
emphasis on evidence in the CIRSE scientific programme.
Special Sessions will also give updates on the management of
abdominal and thoracic aortic disease, renal denervation,
hepatic, portal and mesenteric thrombosis and upper extremity
peripheral vascular disease. As venous disease is becoming an
increasing part of the workload of interventional radiologists,
there will be Special Sessions on varicose veins, thrombolysis of
deep venous thrombosis and haemodialysis. The Controversies
Sessions involving debates continue to be popular, and this
year’s sessions will be on the management of aortic disease,
endoleaks, peripheral vascular intervention and portal hypertension. Delegates wishing to learn in an informal atmosphere
by working up cases with experts are encouraged to attend
the Workshops and Interactive Case Sessions, which will focus
on important aspects of vascular interventions, such as varicose
veins, lower extremity occlusive disease, endoleak management and the management of chylothorax. There will be a
new Hands-on Workshop devoted to renal denervation, which
will involve the range of new devices available for this exciting
procedure. The Hands-on Workshop on Closure Devices is still
enjoying great popularity and will again be part of the CIRSE
programme in 2013, with the added feature of including
percutaneous large vessel closure devices for endovascular
aortic procedures.
Interventional oncology will occupy a deservedly prominent
place in the CIRSE 2013 programme, with the aim of illustrating
new advances in the field. The Scientific Programme Committee
has endeavoured to create exciting sessions, featuring updates
on oncological interventions that will be essential viewing for
experts, as well as sessions that will appeal to IRs who want to
become more involved in interventional oncology. This year,
one of the Hot Topic Symposia – an integral feature of the
CIRSE programme – will be devoted to the role of interventio
nal oncology in lung cancer. A high-level international faculty
will discuss the new developments in this field and how inter
ventional oncologists can play a role in the management of
lung cancer. In the Special Sessions programme, there will be
two Evidence Forum sessions on the management of hepato
cellular carcinoma and colorectal metastases. The aim of these
sessions will be to review the outcomes of the major trials of
all competing therapies for these diseases, with a summarising
conclusion given by the moderator of each session, whose role
it will be to provide recommendations regarding the best treatment methods based on the available evidence. Other high
lights of the Special Sessions will be high intensity focused
ultrasound (HIFU), irreversible electroporation and new platforms
for drug delivery in interventional oncology. Furthermore, there
will be Special Sessions on renal tumour ablation and new clinical
applications for interventional oncologists. Ablation techniques
for different types of cancer will also be discussed in the onco
logy Workshops and Hands-on Workshops, where the particu
larly popular sessions “Starting your practice” and “Liver” will
again take place twice, in order to give more delegates the
opportunity to attend. Participants will be able to access the
full range of ablation systems (RFA, cryotherapy, microwave,
electroporation). Increased focus will be given to ultrasoundguided procedures in a “How I do it” format. Highlights will
include radioembolization and portal vein embolization.
C RSE
Barcelona 2013
Transcatheter Embolization
Transcatheter embolization, now an integral part of the daily
practice of most interventional radiologists, will continue to be
represented by an extensive educational programme at CIRSE
2013. There will be three Foundation Course sessions devoted
to embolization, focusing on gastrointestinal haemorrhage, female genito-urinary embolization and vascular malformations.
All Foundation Course lectures will be delivered in a “How I do
it” format, and are aimed at trainees in IR or newly qualified IRs.
As usual, there will also be a comprehensive programme of Special
Sessions and Workshops which will cover all facets of emboliza
tion therapy. The main Special Session topics will be uterine
artery embolization, embolization in the thorax, visceral artery
aneurysms, trauma and an exciting session entitled “Prostate
artery embolization: real benefit or myth?”. Delegates are also
encouraged to attend the Interactive Case Session on haemorrhage, which will provide the opportunity to learn in a more
informal and interactive atmosphere. There will be a series of
embolotherapy Workshops and all will involve case-based dis
cussions to illustrate the topics. The “Embolization: materials and
tools” Hands-on Workshop has become one of the highlights of
the practical programme at CIRSE, giving participants insight into
the manipulation of the available embolization tools and mate
rials, such as liquid and particulate agents, glue, coils and plugs.
Neuro interventions
After attracting major interest from CIRSE delegates in 2011,
the neuro interventions track experienced a significant increase
in session attendance in Lisbon in 2012, with most rooms filled
to capacity. More and more vascular interventional radiologists
in Europe are becoming involved in neuro interventions, parti
cularly in the management of acute stroke. With this in mind,
the neuro programme for 2013 has been expanded and will
include two Foundation Course sessions, two Special Sessions,
three Workshops and a Hot Topic Symposium. We envisage
that the Hot Topic Symposium on the role of interventional
radiologists in the management of acute stroke will be one of
the 2013 congress highlights. Senior interventional radiologists
and senior neuroradiologists will discuss several important
aspects of this topic. The two new Foundation Course sessions,
aimed at interventional radiologists who wish to become more
involved in stroke therapy, will contain lectures that will discuss
all relevant aspects of stroke therapy for interested IRs. Special
Session and Workshop topics will include carotid and vertebral
intervention, fundamentals of intracerebral aneurysms and
vascular malformation management, and the management
of epistaxis. There will be two Hands-on Workshops on stroke
therapy. Participants will have the opportunity to test several
devices specifically designed for intracranial thrombectomy in
a simulator or flow model under the supervision of wellrecognised experts in this field.
Main Themes
Non-vascular Interventions
This year, the programme committee has composed three
Foundation Course sessions, three Special Sessions, five
Workshops, and two Interactive Case Sessions in the nonvascular field. Foundation Course sessions are aimed at trainee
IRs and IRs who wish to broaden their practice into new areas.
The Foundation Course topics in 2013 will be spine interventions, biliary interventions and biopsy and abscess drainage,
all in a “How I do it” format. Besides Special Sessions on the
role of non-vascular IR in gastrointestinal and genito-urinary
intervention, there will be a session on “New horizons in
musculoskeletal interventions”, which will include lectures
on percutaneous screw fixation of fractures and MR-guided
interventions. Peripheral bone interventions, MSK ultrasoundguided procedures and acute pancreatitis will be among the
Workshop topics for CIRSE 2013. The CIRSE 2012 Hands-on
Workshops on “Vertebral augmentation techniques” proved,
as ever, to be a great success and will again be held in 2013.
Three sessions will be offered in which participants will have
the opportunity to practice needle placement, cement
preparation and injection.
IR Management
CIRSE encourages interventional radiologists to become in
volved in IR management, as clinical care is an important aspect of practice in Interventional Radiology. The introduction
of IR management at CIRSE 2011 was a great success and it con
tinued to be popular at CIRSE 2012. Accordingly, the IR manage
ment programme has been expanded for the CIRSE 2013 programme. Besides a Special Session focusing on radiation dose
management and anaesthesia, sedation and analgesia, there
will be an exciting session on training and accreditation for IRs.
This session will discuss the new CIRSE IR curriculum, the role
of the EBIR and other issues, such as the pros and cons of re
certification. Furthermore, a Special Session will be dedicated
to clinical practice for IRs in the management of lower limb
occlusive disease. This session will explore how IRs can provide
total management of the patient with lower limb arterial disease. In the Workshop programme, there will be a Workshop
entitled “How to pass the EBIR”. Aspects of IR management
will not only be dealt with in sessions specifically labelled as
“IR Management” topics. Issues such as patient referral, the
relationship with other clinical services and the management
and follow-up of patients will be addressed in many sessions,
producing a common pathway throughout the whole session
programme.
17
18
Session Types
CIRSE Session Types
Amazing Interventions
The aim of this new session is to present examples of unusual
and difficult interventional procedures. Acclaimed experts in interventional radiology will present brief cases of their most un
usual and challenging procedures. The emphasis of the session
will be to highlight innovative ways that interventional radiolo
gists can solve difficult problems and get out of trouble. It is envisaged that the session will be both educational and entertaining.
“CIRSE meets …” Session
The “CIRSE meets …“ programme proved to be an important
platform for establishing and strengthening the relations
between CIRSE and its distinguished Group Members – the
National Societies in the field of Interventional Radiology.
For the detailed programme, please refer to page 15.
Evidence Forums
Evidence Forums are a new type of Special Session focusing on
the outcomes of major trials investigating devices or techniques
for conditions commonly treated by interventional radiologists.
Each forum will consist of several short talks presented by
leaders in the field. Each speaker will present the evidence for
and against the use of a specific device or technique for the
treatment of the disease under evaluation. At the end of the
session, the moderator will summarize the evidence presented
and provide conclusions regarding the best method of
treatment based on the current evidence.
Film Interpretation Quiz
The Film Interpretation Quiz is one of CIRSE’s most popular
sessions and will be run as a “last man standing” quiz. The Quiz
Master will present the audience with two possible answers to
each case – those choosing incorrectly will be eliminated and
must sit down, while those who get the answer right will continue to the next case. The last few contestants left standing
will be invited onstage for a head-to-head finale.
Foundation Courses
Foundation Courses cover a specific area of Interventional
Radiology, focusing on basic principles and illustrating the
procedure in a step-by-step fashion. They are designed for
radiologists in training and new consultants, as well as for
experienced consultants who require a refresher course on
the subject. There will be plenty of time for questions and
discussion. Each session will last one hour.
For the detailed programme, please refer to pages 22-23.
Free Paper Sessions
Researchers will present original papers on new and original
aspects of Cardiovascular and Interventional Radiology. Selected
papers will be gathered into sessions, each dealing with a
homogenous topic. There will be time for discussion between
researchers and attendees after each presentation.
Featured Papers:
In order to achieve a more interactive format to the Free Paper
sessions, one paper per session will be highlighted. More time
will be dedicated to this featured paper by means of further
questions prepared prior to the meeting by the moderator.
This will ensure a more structured and thorough discussion of
the topic.
Hands-on Workshops
The participants of Hands-on Workshops can follow live demon
strations of interventional techniques and practice certain procedures under the guidance of a technician and/or instructor.
Hot Topic Symposia
The Hot Topic Symposia aim to address important IR topics that
are current and controversial in the setting of a plenary session.
Invited speakers will give brief lectures on important aspects of
the subject under discussion. A major feature of these sessions
will be a round table discussion involving the speakers and the
audience.
Interactive Case Sessions
CIRSE‘s Interactive Case Sessions are divided into several topics.
After two presenters have shown individual cases, the audience
is asked for its opinion on treatment. These interactive sessions
provide an excellent learning experience on how to approach and
work up difficult cases and deal with complications that may arise.
Morbidity & Mortality Conference
The Morbidity and Mortality Conference will analyse Interventio
nal Radiology cases which led to complications and/or deaths that
could have been avoided. This session provides a valuable learning
experience for everyone involved in Interventional Radiology.
The session will be dedicated to vascular and non-vascular cases.
Satellite Symposia
Satellite Symposia are organised by industrial companies and
take place at lunchtime as well as in the morning and in the
evening in order to avoid time conflicts with the main scientific
programme. During these sessions cutting-edge information
on interventional equipment and techniques is provided.
The Satellite Symposia programme will be published in the
final programme.
Special Sessions
Special Sessions are designed to impart the latest knowledge
on topics of interest to interventional specialists. These sessions
are the backbone of the CIRSE meeting and are specifically
chosen by the programme planning committee because of
their importance in daily practice.
Workshops
During Workshops you will have the chance to learn from your
colleagues’ expertise in an informal, interactive manner. Work
shops will entail individual cases and discussion points with
regard to the particular interventional topic. Attendees can
contribute their opinions and ask questions in small groups.
Barcelona 2013
Exhibitors
Exhibitors
The CIRSE Annual Scientific and postgraduate Educational
Meeting has established itself as the leading gathering for
all professionals devoted to the field of Cardiovascular and
Interventional Radiology in Europe. CIRSE 2012 saw an
attendance of over 6,100 participants from 85 countries
worldwide. More than 110 companies took the opportunity
to promote their products.
CIRSE’s technical exhibition features the largest and most
comprehensive assembly of cutting edge equipment and
devices for image-guided minimally invasive therapy in
Europe. CIRSE would like to thank the following companies
for their participation at CIRSE 2012 and looks forward to
welcome them again in Barcelona for CIRSE 2013!
Aachen Resonance
Abbott Vascular
ALN Implants Chirurgicaux
amedo Smart Tracking Solutions
Andanza
Andramed
AngioDynamics
Argon Medical Devices
ArtVentive Medical
Atrium
B.Braun Medical
Bard
Bayer Healthcare
Bioteque
Biotronik
Bolton Medical
Boston Scientific
Bracco
BSD Medical
CeloNova BioSciences
Chongqing Haifu (HIFU) Technology
CID
CIVCO Medical Solutions
Control Medical Technology
Cook Medical
Cordis, Johnson & Johnson
Covidien
Crux Biomedical
Delcath Systems
DePuy Synthes
DFine
Ekos
Elastrat
Endocor
Endologix
eucatech
Eurocor
Galil Medical
GEM
GO Medical
Gore & Associates
HS Hospital Service
Imaging Management
InSightec
Intio
iSYS Medizintechnik
Joline/translumina
Kimal
Lifetech Scientific
Lombard Medical
MDT Medical Instruments
Medcomp
Medex Research
Medtronic
Mentice
Merit Medical Systems
Möller Medical
NeoRad
NeuroTherm
Nordion
Olympus Surgical Technologies
OptiMed Medizinische Instrumente
Oscor
Pajunk
Penumbra
Perfint Healthcare
Perouse Medical
phenox
Philips Medical Systems
Qessential
QualiMed Innovative Medizinprodukte
RF Medical
Siemens
Simbionix
Sirtex Medical
Spectranetics
St. Jude Medical
STARmed
Sterylab
Straub Medical
Surefire Medical
Synergy
Tecres
Teleflex Medical
TeraRecon
Terumo
Toshiba Medical Systems
TriVascular
UreSil
Urotech
Vascular Solutions
Vidacare
19
EBI R
Certify your Expertise
in Interventional Radiology
The EBIR is the European interventional radiology
qualification, and aims to standardise the
profession’s training and expertise in
interventional radiology across Europe.
Register now for the
next EBIR examination,
which will take place during
CIRSE 2013 in Barcelona.
Don’t miss your chance!
For application deadlines and detailed information,
please visit our website at www.cirse.org/ebir
The CIRSE EBIR Department
Neutorgasse 9/6, 1010 Vienna, Austria
www.cirse.org/ebir
[email protected]
C RSE
September 14-18
Barcelona, Spain
CIRSE 2013
22-23
24-27
28-29
30
31-34
35-38
39-41
42-44
45
46-51
Foundation Courses
Hot Topic Symposia
Evidence Forums
Monday, September 16
Wednesday, September 18
Hands-on Workshops
in the spotlight
Foundation Courses
The Essentials of Transcatheter Embolization
Foundation Courses cover a specific area of
Interventional Radiology, focusing on basic
principles and illustrating the procedure in a
step-by-step fashion. They are designed for
radiologists in training, new consultants and/or
experienced consultants who require a refresher
course on the subject. There will be plenty of time
for questions and discussion. Each session lasts
one hour. This year, the courses will cover the
topics “Transcatheter Embolization”,
“Neuro Interventions” and “Non-Vascular
Interventions”.
08:30-09:30
FC 101 Gastrointestinal haemorrhage:
how I do it
101.1 Diagnosis and localisation
M. Darcy (St. Louis, MO/US)
101.2 Embolize upper GI haemorrhage
R. Loffroy (Dijon/FR)
101.3 Embolize lower GI haemorrhage
J. Golzarian (Minneapolis, MN/US)
101.4 Diagnose and treat chronic GI haemorrhage
L. Defreyne (Ghent/BE)
10:00-11:00
FC 201 Female genito-urinary embolization:
how I do it
201.1 Manage life-threatening post-partum
haemorrhage
O. Pellerin (Paris/FR)
201.2 Manage placental abnormalities
J.-P. Pelage (Caen/FR)
201.3 Uterine artery embolization: patient
selection and technique
T.J. Kroencke (Berlin/DE)
201.4 Ovarian vein embolization: patient
selection and technique
A. Basile (Catania/IT)
11:30-12:30
FC 301 Vascular malformations: how I do it
301.1 Diagnosis: imaging strategy
M. Köcher (Olomouc/CZ)
301.2 Treat peripheral low flow malformations
J.P. Burnes (Clayton, VIC/AU)
301.3 Treat peripheral high flow malformations
B. Peynircioglu (Ankara/TR)
301.4 Treat large visceral malformations
J.E. Jackson (London/UK)
C RSE
The Essentials of Neuro Interventions
The Essentials of Non-Vascular Interventions
08:30-09:30
FC 901 Stroke management 1: how I do it
11:30-12:30
FC 1101 Spine interventions: how I do it
1101.1 Spinal approach and bone biopsy
R.-T. Hoffmann (Dresden/DE)
1101.2Vertebroplasty
A.D. Kelekis (Athens/GR)
1101.3 Balloon augmentation/stentoplasty
C.A. Binkert (Winterthur/CH)
1101.4 Facet joints and discs
D.K. Filippiadis (Athens/GR)
901.1 What do you need to know about imaging
in acute stroke?
K.A. Hausegger (Klagenfurt/AT)
901.2 How to decide when to perform intraarterial thrombolysis/thrombectomy (IAT)
A. Berlis (Augsburg/DE)
901.3 Logistics of IAT in acute stroke patients
H. van Overhagen (The Hague/NL)
901.4 Which devices should I use in which
patients?
A. Clifton (London/UK)
10:00-11:00
FC 1001 Stroke management 2: how I do it
1001.1 How I perform thrombolysis and
thrombectomy
C. Castaño (Badalona Barcelona/ES)
1001.2 What influences the outcomes of IAT?
to be announced
1001.3 Clinical outcomes after IAT – trial update
P. Brennan (Dublin/IE)
1001.4 How to prevent and manage complications
of IAT
R. Barranco Pons (Barcelona/ES)
08:30-09:30
FC 1701 Biliary interventions: how I do it
1701.1 Biliary stenting and drainage
B.S. Tan (Singapore/SG)
1701.2 Manage benign biliary strictures and stones
M. Ryan (Dublin/IE)
1701.3 Percutaneous cholecystostomy
A. Sibert (Clichy/FR)
1701.4 Manage complications of biliary and
gall bladder interventions
D.F. Martin (Manchester/UK)
10:00-11:00
FC 1801 Biopsy and abscess drainage: how I do it
1801.1 Lung and mediastinal biopsy
T. Sabharwal (London/UK)
1801.2 Abdominal and pelvic biopsy
M. Düx (Frankfurt/DE)
1801.3 Empyema, lung abscess and mediastinal
drainage
O. Akhan (Ankara/TR)
1801.4 Abdominal and pelvic abscess drainage
P.R. Mueller (Boston, MA/US)
in the spotlight
Intra-arterial stroke management –
should this be an IR procedure?
The involvement of interventional radiology in the management of stroke has increased in
recent years. This is in line with the rising prevalence of endovascular treatment modalities,
including embolization for haemorrhagic stroke and thrombolysis, thrombectomy and
recanalisation for ischaemic stroke. The timely application of these interventions has proven
to be a beneficial addition to the armoury of stroke treatments.
As the incidence of stroke is set to rise with the ageing population, rapid access to the most
advanced and effective treatments is not only of great importance today but will be even more
so in the future. In order to guarantee the safe provision of sophisticated neurointerventional
techniques it is vital that experienced and well-trained experts are available to meet demand.
Many interventional radiologists are already involved in endovascular stroke treatment by
virtue of their relevant and extensive education, training and experience. Aside from the
recognised advantages of general multidisciplinary stroke care, the involvement of other
specialties in the delivery of endovascular treatments has become a topic of discussion,
particularly regarding the establishment of common training programmes and the
standardisation of competence.
Further to issues of individual competence are logistical concerns about how best to
organise medical expertise to serve patient needs, in terms of both geographical
coverage and quality of treatment.
The potentially huge growth in this field and the wider implications for IR of the
connected issues means that discussion of this topic is as much of interest to general
interventional radiologists as it is to those already closely involved in the area.
C RSE
Tommy Andersson
Klaus A. Hausegger
Jim A. Reekers
Dierk Vorwerk
Hot Topic Symposium
The scientific programme at CIRSE 2013 features a range of sessions on the theory and practice of
stroke management. The Hot Topic Symposium on intra-arterial stroke management is a perfect
complement to these sessions as it addresses concerns and issues around the provision of treatments
including the balancing of quality and capacity. The session not only deals with the status quo but also
looks ahead to how IR can be more strongly integrated into stroke management and how the best results
for patients can be guaranteed.
As training is the foundation of procedural competence, Prof. Dierk Vorwerk (Ingolstadt/DE) will
start the session with a description of recent developments relating to training frameworks for
neuroradiologists as well as for other specialties who are involved in the delivery of neurointerventions.
The background to training having been explored, Dr. Tommy Andersson (Stockholm/SE) will
continue by considering the provision of intra-arterial thrombectomy, which has had a large impact
on modern stroke treatment and is set to become even more significant in the future. It is known that
neurovascular centres with a high case load build greater expertise, in light of this the question of
whether this important procedure should only be performed by dedicated neuroradiologists is up for
discussion.
In the spirit of debate, Prof. Klaus Hausegger (Klagenfurt/AT) will respond by considering whether well
trained “general interventionalists“ have the necessary skills and knowledge to safely perform intraarterial thrombectomy and what implications this may have for service provision. Having established
this, Prof. Dierk Vorwerk will again take to the podium to consider the extent to which general IRs are
already involved in stroke therapy across Europe.
Prof. Jim Reekers (Amsterdam/NL) will conclude the session by discussing possible strategies for the
future involvement of IRs in the provision of acute stroke therapy and what this would mean for IR and
for patient care.
Sunday, September 15, 15:00-16:00
HTS 1302 Intra-arterial stroke management – should this be an IR procedure?
1302.1 Recent developments regarding the training of neuroradiologists and other specialties
for neurointerventions
D. Vorwerk (Ingolstadt/DE)
1302.2 Intra-arterial thrombectomy should only be performed by dedicated neuroradiologists
T. Andersson (Stockholm/SE)
1302.3 Intra-arterial thrombectomy can be safely performed by a well-trained
“general interventionalist“
1302.4 How much are general IRs involved in stroke therapy across Europe?
1302.5 A plan for the future involvement of IRs in the provision of acute stroke therapy
J.A. Reekers (Amsterdam/NL)
26
in the spotlight
Treatment of lung cancer –
the choices, and how to make them
Interventional oncology has been making incredible progress in recent years, and already,
IR therapies for liver cancers are well accepted and widely used. However, exacting
research is also being conducted into other cancer types, with some impressive results.
Lung cancer therapy is an area where IR is showing real potential. Various principles
(thermal ablation; mechanical ablation; embolization) have been investigated in lung tumour
models, and data is now available to support their use in certain clinical settings, particularly
radiofrequency ablation.
Good patient selection is a crucial factor in achieving positive outcomes. A thorough
knowledge of the technology to be used is essential, as is an awareness of the limitations of the
planned treatment.
Patient selection
So far, data suggest that the ideal RFA candidate suffers from stage I non-small cell lung cancer (NSCLC)
which is either surgically inoperable or at high risk for lobectomy or pneumonectomy. Multiple studies
show that tumours to be treated by RFA should be <3cm, as it is difficult to ensure complete ablation
in larger targets. Location <1cm from the main bronchi is an absolute contraindication, as is association
with atelectasis or obstructive pneumonitis, and unmanageable coagulopathy. However, contact with
the visceral pleura is not a contraindication, as possible pleural effusion or increased pain can be easily
managed.
Although it is currently accepted that RFA should be reserved for surgically inoperable patients (largely
due to the associated difficulty in assuring complete tumour destruction and in sampling the tumour
tissue), data from the Institut Gustave Roussy suggests that this prescription may not be absolute:
strangely, their study reported better survival outcomes for the >70 age group. This anomaly is most
likely due to the inclusion criteria – patients below this age were those deemed inoperable due to the
tumour location or co-morbidities, while all patients over 70 were deemed inoperable primarily due to
their age, and thus RFA was performed on less complex tumour presentations in that age group.
Nonetheless, good patient selection remains a key indicator of outcomes, along with suitable imaging,
anaesthesia and patient positioning (both in terms of trajectory of the needle and tumour mobility).
Technical limitations
Understanding the limitations of your technology is also crucial, and can allow creative solutions to
possible complications. Thermal damage to nerves and other structures can be avoided by judicious
use of air protection or a fluid buffer, such as a 5% glucose solution.
RFA and other thermal technologies can be negatively affected by vessel proximity, as the heat-sink
effect prevents a complete ablation. There are several options to overcome this limitation, including
sequential activation or use of an alternative energy source, such as microwave ablation or irreversible
electroporation. MWA also allows larger burn-zones, which allows for the destruction of more bulky
tumours.
C RSE
27
Barcelona 2013
Thierry de Baère
Afshin Gangi
Lizbeth M. Kenny
José Vilar
Hot Topic Symposium
This Hot Topic Symposium will approach the topic from a number of angles, painting a full picture of
the considerations and skills needed to provide these cutting-edge therapies.
Dr. José Vilar (Valencia/ES) will be discussing the imaging modalities available to guide the treatment
of lung cancer. CT modalities are currently the most widely used, with spiral CT enjoying favour among
many who are investigating ablation of lung cancers. Fluoro-CT can offer contrast-free imaging, while
contrast-enhanced CT can demonstrate morphology and enhancement pattern. The use of PET-CT and
diffusion-weighted MR are also under investigation for this treatment.
Various forms of thermal ablation will be discussed by Dr. Thierry de Baère (Villejuif/FR), who has been
researching this field for many years, and who was one of the authors in the Institut Gustave Roussy
study. Dr. de Baère will present the data from leading studies, and analyse whether this data indicates
that thermal ablation for NSCLC should be offered routinely as part of a hospital’s oncology regimens.
Prof. Afshin Gangi (Strasbourg/FR) will examine the case for the use of cryotherapy in the lungs and
thoracic wall, using his own extensive research and data to give the most up-to-date overview of this
novel therapy. Although less widely used than technologies like RFA or MWA, cryotherapy offers a
number of unusual features that can be of benefit in tumour destruction, and Prof. Gangi will discuss
whether these benefits transfer well to the pulmonary setting.
To ensure a valuable balance in these discussions, radiation oncologist Dr. Lisbeth Kenny (Brisbane,
QLD/AU) will offer her insights into choosing the right therapy for a lung cancer patient. She will weigh
up not only how to decide whether a patient should receive treatment for their particular condition,
but if so, how the correct course of therapy can be selected by a multidisciplinary team.
Tuesday, September 17, 13:30-14:30
HTS 2802 Treatment of lung cancer – the choices, and how to make them
2802.1 The role of imaging in guiding the treatment of lung cancer
J. Vilar (Valencia/ES)
2802.2 Thermal ablation: research or mainstream therapy?
T. de Baère (Villejuif/FR)
2802.3 Percutaneous cryotherapy in the lungs and the thoracic wall
A. Gangi (Strasbourg/FR)
2802.4 Radiation therapy: the oncologist’s view of how to choose whether and how to treat
L.M. Kenny (Brisbane, QLD/AU)
in the spotlight
CIRSE Considers the Evidence
Keeping pace with the latest developments in interventional medicine, CIRSE 2013
sees the introduction of a new session type into the scientific programme. Evidence
Forums will see the most up-to-date research summarised and discussed in the
context of relevant questions arising in current practice. Among the topics this year
are superficial femoral artery interventions and below-the-knee interventions, in
both cases the question will be asked whether we know the optimal treatment yet.
Evidence forum:
SFA – do we know the optimal treatment yet?
Image courtesy of Prof. Stefan Müller-Hülsbeck
A range of devices and techniques are now available
for revascularisation of the superficial femoral artery
in peripheral arterial disease. These treatments offer
great potential in reducing morbidity and restoring
quality of life. However, in light of the latest studies
and the volume of data now available there is a need
to compare strategies carefully. This is essential if
interventional radiologists are to offer an optimal and
evidence-based approach for each patient.
In this forum, clinical data on a wide spectrum of
endovascular SFA technologies will be compared,
including drug-eluting and covered stents as compared
to bare metal stents, as well as drug-eluting balloons
and atherectomy with cutting balloons.
The session will end with a summary of the evidence
and conclusions will be drawn by the experts in a pa
nel discussion, considering if there is indeed a current
“optimal treatment” or if further investigations and
longer term trial results are needed in particular areas.
Sunday, September 15,
11:30-12:30
SS 1102 Evidence forum:
SFA – do we know the
optimal treatment yet?
1102.1 Bare metallic stents
S. Müller-Hülsbeck (Flensburg/DE)
1102.2 Drug-eluting stents
P.A. Gaines (Sheffield/UK)
1102.3Stent-grafts
M. Schoder (Vienna/AT)
1102.4 Drug-eluting balloons
G. Tepe (Rosenheim/DE)
1102.5 Atherectomy, cutting balloons
M.S. Hamady (London/UK)
1102.6 Summary of evidence
and panel discussion
new
SFA and BTK interventions
Peripheral arterial disease is on the rise, and is a cause for great concern. As the traditional
response to the ischaemia and non-healing ulcers that arise from this disease is amputation, it
can be costly in both economic and social terms. A commonly quoted figure is that somewhere
in the world, a leg will be lost to diabetes every 30 seconds. Even with the wealth of IR options
available, up to 67% of CLI patients in the USA have a primary amputation as their initial
treatment – a staggering figure when one considers that recanalisation techniques can lower
the amputation rate in CLI patients from 73-95% down to just 25%.
Evidence forum:
BTK – do we know the optimal treatment yet?
Image courtesy of Dr. Massimiliano Di Primio
Below-the-knee interventions rightly occupy an
important place in the armoury of IR procedures. Not
only can they be considered the first true IR therapy,
but their refinement over the last 50 years, in tandem
with the simultaneous rise in both life-expectancy
and incidence of diabetes, leaves below-the-knee
interventions more needed than ever.
PTA is widely held to be the primary treatment for
lower-limb occlusions, and despite high restenosis
rates, it achieves excellent limb-salvage results.
Retreatment is always an option, and assisted and
secondary patency rates are very high. Advances in
stent and balloon technologies (along with dedicated
catheters and guidewires) allow IRs to treat a wide
range of BTK lesions, both long and short.
However, navigating all these options can prove diffi
cult, and an overview of the evidence and indications
for some of these techniques and tools will be provided
by experts in the field, followed by a panel discussion
and questions from the audience.
Monday, September 16,
08:30-09:30
SS 1702 Evidence forum:
BTK – do we know the
optimal treatment yet?
1702.1PTA
J.H. Peregrin (Prague/CZ)
1702.2 Bare stents
T. Jahnke (Neumünster/DE)
M. Di Primio (Paris/FR)
T.W.I. Clark (Philadelphia, PA/US)
1702.5 Stem cell and gene therapy
S. Sharma (Delhi/IN)
1702.6 Summary of evidence
and panel discussion
30
Workshops for radiographers
Interventional Radiology is very much a team effort.
Optimal patient care can only be delivered if the physician
and the other team members, such as radiographers, are
well trained and highly professional in what they do.
A growing number of radiographers working in the field of
Interventional Radiology are attending the annual CIRSE
congress. In order to cater to this development, CIRSE and
the European Federation of Radiographer Societies (EFRS)
are organising two interactive workshops especially
designed for radiographers and nurses.
10:00-11:00
RWS 206 EFRS Workshop 1
Organization and operational standards for
IR service
10:00-11:00
Radiation protection for patients and staff
in interventional procedures
206.1
C. Ciaralli (Rome/IT)
206.2
S. Panci (Florence/IT)
1006.1
R.D. Silkoset (Østerås/NO)
1006.2
A. Widmark (Østerås/NO)
Learning objectives
After active participation in this workshop including the pre
sentation of the AITRI (Italian Association of Interventional
Radiographers) guidelines, attendees will have gained better
knowledge and understanding of:
• the activities and methods necessary to establish an Inter
ventional Radiology (IR) service according to the volume and
type of diagnostic tests and therapeutic treatments performed
• how to evaluate the needs (materials and devices) of the IR
service and how to supply and manage human resources
• the level of collaboration necessary between the different
professionals involved (interaction, tasks and competences)
• the responsibility of radiation protection and supervision of
the maintenance of operational standards and appropriate
criteria
• training and up-to-date courses for health professionals
Learning objectives
After active participation in this workshop attendees will have
gained better knowledge and understanding of:
• the principles of radiological protection in fluoroscopically
guided interventions
• protection of staff during interventional fluoroscopy
• recommended radiological protection training for staff
• the radiation risk factors and possible harm in Interventional
Radiology for staff and patients
– dose limits for staff
– the eye lense and radiation (cataract)
– examples of tissue reactions
A series of two workshops organised in co-operation with the
C RSE
Barcelona 2013
08:30-09:30
FC 101 Foundation Course
Gastrointestinal haemorrhage: how I do it
101.1 Diagnosis and localisation
M. Darcy (St. Louis, MO/US)
101.2 Embolize upper GI haemorrhage
R. Loffroy (Dijon/FR)
101.3 Embolize lower GI haemorrhage
101.4 Diagnose and treat chronic GI haemorrhage
L. Defreyne (Ghent/BE)
08:30-09:30
SS 102 Special Session
Upper extremity PVD
102.1 Optimal imaging assessment for supra-aortic and
upper limb arterial disease
C. Hohl (Siegburg/DE)
102.2 How can we improve our results for the treatment
of subclavian artery occlusions? – Tips and tricks
S. Macdonald (Newcastle-upon-Tyne/UK)
102.3 Is there a role for PTA and/or stenting for disease
distal to the subclavian arteries?
S.D. Qanadli (Lausanne/CH)
102.4 How should we treat aneurysms and pseudo
aneurysms of the upper extremity arteries?
E. Brountzos (Athens/GR)
08:30-09:30
Training and accreditation for IRs
103.1 How does IR training vary across Europe?
P. Reimer (Karlsruhe/DE)
103.2 How will the EBIR and the new curriculum help
training and accreditation?
A.-M. Belli (London/UK)
103.3 Arguments for and against recertification
J.A. Kaufman (Portland, OR/US)
103.4 Should IR become a separate subspecialty?
I. Robertson (Glasgow/UK)
08:30-09:30
Advances in image guidance for
interventional oncology procedures
104.1 New developments in guidance and navigation
N. Abi-Jaoudeh (Bethesda, MD/US)
104.2 Non-contrast fusion road-mapping:
how can it help?
M.J.L. van Strijen (Nieuwegein/NL)
104.3 Stereotaxy and robotic assistance:
where are we now?
R. Bale (Innsbruck/AT)
104.4 Intraprocedural evaluation
G. Soulez (Montreal, QC/CA)
08:30-13:00
PTP-HoW 1 Hands-on Workshop
Principles to practice: education and
simulation skills training / renal denervation
Coordinators: D.O. Kessel (Leeds/UK),
PTP 1.1 Group 1 (08:30-10:40)
PTP 1.2 Group 2 (09:40-11:50)
PTP 1.3 Group 3 (10:50-13:00)
10:00-11:00
Female genito-urinary embolization:
how I do it
201.1 Manage life-threatening post-partum haemorrhage
201.2 Manage placental abnormalities
201.3 Uterine artery embolization: patient selection
and technique
T.J. Kroencke (Berlin/DE)
201.4 Ovarian vein embolization: patient selection
and technique
A. Basile (Catania/IT)
31
32
10:00-11:00
Aortoiliac disease
202.1 Which is the best imaging modality for
preprocedural assessment?
M. Das (Maastricht/NL)
202.2 Are re-entry devices useful in chronic
iliac occlusions?
A. Buecker (Homburg/DE)
202.3 Do we know the best treatment for different
TASC lesions: PTA vs. bare metal stents vs.
covered stents
T. Rand (Vienna/AT)
202.4 Can interventional radiologists treat acute
aortoiliac artery occlusion?
W. Jaschke (Innsbruck/AT)
10:00-11:00
Gastrointestinal and genito-urinary
interventions forum
10:00-11:00
Preventative stroke management
203.1 What we know about atherosclerotic plaques:
non-invasive morphologic imaging
A.H. Mahnken (Marburg/DE)
203.2 Prevention of imminent or recurrent stroke with
medical therapy or non-radiologic intervention
H.S. Markus (London/UK)
203.3 Extracranial stenting: indications and techniques
A. González García (Sevilla/ES)
203.4 Intracranial stenting: indications and techniques
C.P. Stracke (Bonn/DE)
205.1 Sclerotherapy of renal and hepatic cysts
205.2 Current status of upper GI stenting
H.-Y. Song (Seoul/KR)
205.3 Biodegradable, retrievable and drug-eluting stents
in the biliary tract
M.E. Giménez (Buenos Aires/AR)
205.4 Fallopian tube recanalization
M. Szczerbo-Trojanowska (Lublin/PL)
10:00-11:00
Organization and operational standards for
IR service
206.1 C. Ciaralli (Rome/IT)
206.2 S. Panci (Florence/IT)
10:00-11:00
New clinical applications for
interventional oncologists 1
204.1 Desmoid tumours
G. Tsoumakidou (Strasbourg/FR)
204.2 Malignant melanoma
C.W. Nutting (Englewood, CO/US)
204.3 Neuroendocrine tumours
F. Orsi (Milan/IT)
204.4 Cholangiocarcinoma
J.B. Karani (London/UK)
11:30-12:30
Vascular malformations: how I do it
301.1 Diagnosis: imaging strategy
M. Köcher (Olomouc/CZ)
301.2 Treat peripheral low flow malformations
J.P. Burnes (Clayton, VIC/AU)
301.3 Treat peripheral high flow malformations
B. Peynircioglu (Ankara/TR)
301.4 Treat large visceral malformations
J.E. Jackson (London/UK)
11:30-12:30
ICS 302 Interactive Case Session
Challenging lower limb recanalization
302.1 L. Boyer (Clermont-Ferrand/FR)
302.2 D. Karnabatidis (Patras/GR)
C RSE
Barcelona 2013
11:30-12:30
Hepatic, portal and mesenteric vein thrombosis
14:30-16:00
OP 501 CIRSE Opening Ceremony and Awards
303.1 Clinical presentation and management of hepatic
vein occlusive disease
Y.H. Kim (Daegu/KR)
303.2 IR management of Budd-Chiari syndrome
A. Krajina (Hradec Králové/CZ)
303.3 Clinical presentation and medical management of
acute and chronic portomesenteric vein thrombosis
J.C. García-Pagán (Barcelona/ES)
303.4 IR management of acute and chronic
portomesenteric vein thrombosis
I.K. Tesdal (Friedrichshafen/DE)
11:30-12:30
Kidney and lung ablations
304.1 J. Palussière (Bordeaux/FR)
304.2 X. Buy (Bordeaux/FR)
11:30-12:30
Anaesthesia, sedation and analgesia for IR
305.1 Perioperative care: pre-operative patient assessment, optimization and post-operative care
B. Preckel (Amsterdam/NL)
305.2 Sedation and analgesia techniques in IR:
a practical approach
A. Vari (Rome/IT)
305.3 Anaesthesia techniques in IR: a practical approach
C. Batistaki (Athens/GR)
305.4 Locoregional techniques: local anaesthetics to
nerve block
X. Sala Blanch (Barcelona/ES)
12:45-14:15
IVC-HoW 1 Hands-on Workshop
IVC filters
Coordinators: O. Pellerin (Paris/FR),
A.F. Watkinson (Exeter/UK)
16:00-17:30
TA-HoW 2 Hands-on Workshop
Tumour ablation: tips and tricks /
starting your practice
Coordinators: T.K. Helmberger (Munich/DE),
16:15-17:15
WS 601 Workshop
Advanced SFA and BTK interventions:
case-based discussions
601.1 R. Gandini (Rome/IT)
601.2 M. Manzi (Abano Terme/IT)
16:15-17:15
WS 602 Workshop
Paediatric vascular interventions
602.1 A.M. Cahill (Philadelphia, PA/US)
602.2 A.M. Barnacle (London/UK)
16:15-17:15
WS 603 Workshop
Venous lysis and stenting
603.1
T.-E.G. Vrachliotis (Athens/GR)
603.2 F. Boyvat (Ankara/TR)
16:15-17:15
WS 604 Workshop
Advanced UFE: case-based discussions
604.1 N. Hacking (Southampton/UK)
604.2 J. Maskova (Aberdeen/UK)
16:15-17:15
WS 605 Workshop
Peripheral bone interventions: how I do it
605.1 C.S.P. van Rijswijk (Leiden/NL)
605.2 G. Carrafiello (Varese/IT)
12:45-14:15
starting your practice
16:15-17:15
WS 606 Workshop
How to manage neuroendocrine tumours
606.1 W.S. Rilling (Milwaukee, WI/US)
606.2 L. Monfardini (Milan/IT)
13:00-14:00
Satellite Symposia
33
34
17:30-18:30
WS 704 Workshop
Trauma: case-based discussions
16:15-17:15
WS 607 Workshop
Revascularization tools, tips and tricks in
stroke management: case-based discussions
607.1 R. Chapot (Essen/DE)
607.2 H. Henkes (Stuttgart/DE)
17:30-18:30
WS 705 Workshop
ABC of biliary intervention:
16:15-17:15
Satellite Symposia
17:00-18:30
CD-HoW 1 Hands-on Workshop
A closer look at closure devices
Coordinators: S. Müller-Hülsbeck (Flensburg/DE),
J. Tacke (Passau/DE)
701.1 M.W. de Haan (Maastricht/NL)
701.2 K.E. Wilhelm (Bonn/DE)
17:30-18:30
WS 702 Workshop
Tunnelled central venous catheters and ports:
how I do it
705.1 A. Hatzidakis (Iraklion/GR)
705.2 M. Grosso (Cuneo/IT)
17:30-18:30
WS 706 Workshop
Prostate artery embolization: how I do it
17:30-18:30
WS 701 Workshop
Renal artery interventions:
all you need to know
704.1 P.E. Andersen (Odense/DK)
704.2 J. Urbano (Madrid/ES)
706.1 J.M. Pisco (Lisbon/PT)
706.2 F.C. Carnevale (São Paulo/BR)
706.3 J. Golzarian (Minneapolis, MN/US)
17:30-18:30
WS 707 Workshop
Fundamentals of intracerebral aneurysms
and AVM treatment
707.1 M. Piotin (Paris/FR)
707.2 C. Cognard (Toulouse/FR)
702.1 B.S. Funaki (Chicago, IL/US)
702.2 J.M. Lozano (Bogota/CO)
17:30-18:30
WS 703 Workshop
Varicocele and ovarian vein embolization:
703.1 A.C. Roberts (La Jolla, CA/US)
703.2 T. Jargiello (Lublin/PL)
C RSE
Barcelona 2013
08:00-08:20
Satellite Symposia
08:30-09:30
Stroke management 1: how I do it
901.1 What do you need to know about imaging in
acute stroke?
901.2 How to decide when to perform intra-arterial
thrombolysis/thrombectomy (IAT)
A. Berlis (Augsburg/DE)
901.3 Logistics of IAT in acute stroke patients
901.4 Which devices should I use in which patients?
08:30-09:30
Abdominal aorta – update
902.1 Has the percutaneous approach for EVAR reduced
access site complications?
F. Fanelli (Rome/IT)
902.2 Do the new EVAR devices enable us to treat more
patients more effectively?
A. Holden (Auckland/NZ)
902.3 Trials update for elective and emergency EVAR
A. Chavan (Oldenburg/DE)
902.4 Medium and long term outcomes after
fenestrated EVAR – do devices migrate?
A. England (Liverpool/UK)
08:30-09:30
Haemodialysis
903.1 Is shunt surveillance useful: why and how?
M. Roček (Prague/CZ)
903.2 The role of IR in the management of
non-maturing fistulas
L. Turmel-Rodrigues (Tours/FR)
903.3 The role of stents and stent grafts in the
management of failing AV grafts and fistulas
R.B. Shoenfeld (West Orange, NJ/US)
903.4 Venous access options when the thoracic central
veins are lost
M. Guimaraes (Charleston, SC/US)
08:30-09:30
Prostate artery embolization:
real benefit or myth?
904.1 Benign prostatic hypertrophy – the scope
of the problem
N. Thiounn (Paris/FR)
904.2 How can we identify the prostatic arteries during
the procedure?
904.3 How to perform PAE: tips and tricks
F.C. Carnevale (São Paulo/BR)
904.4 What do we know about outcomes of
embolization in 2013?
J.M. Pisco (Lisbon/PT)
08:30-09:30
Renal tumour ablation
905.1 Patient selection: treatment or active surveillance?
905.2 Biopsy, always before ablation?
A.R. van Erkel (Leiden/NL)
905.3 Thermal vs. cryotherapy vs. nephron sparing
surgery – do we know the answer?
D.J. Breen (Southampton/UK)
905.4 Complications after thermal ablation and
cryotherapy of renal tumours: detection and
management
X. Buy (Bordeaux/FR)
08:30-10:00
V V-HoW 1 Hands-on Workshop
Varicose veins
Coordinators: C.A. Binkert (Winterthur/CH),
K.D. McBride (Dunfermline/UK)
08:30-13:00
Principles to practice: education and simulation
skills training / peripheral vascular disease:
getting better outcomes in limb ischaemia
PTP 2.1 Group 4 (08:30-10:40)
PTP 2.2 Group 5 (09:40-11:50)
PTP 2.3 Group 6 (10:50-13:00)
35
36
10:00-11:00
Stroke management 2: how I do it
10:00-11:00
Uterine artery embolization
1001.1 How I perform thrombolysis and thrombectomy
C. Castaño (Badalona Barcelona/ES)
1001.2 What influences the outcomes of IAT?
to be announced
1001.3 Clinical outcomes after IAT – trial update
1001.4 How to prevent and manage complications of IAT
R. Barranco Pons (Barcelona/ES)
10:00-11:00
Thoracic aorta – update
1004.1 Imaging pre and post uterine artery embolization –
how good are new imaging techniques?
L.S. Fournier-Dujardin (Paris/FR)
1004.2 What do we know about uterine-ovarian anastomoses and uterine artery embolization outcomes?
1004.3 How good is uterine artery embolization for
adenomyosis: what do we know?
P.N.M. Lohle (Tilburg/NL)
1004.4 Uterine artery embolization vs. myomectomy:
trials update
J.B. Spies (Washington, DC/US)
1002.1 How good is TEVR for aortic trauma – do the new
devices enable a definitive solution?
T. Pfammatter (Zurich/CH)
1002.2 Adverse outcomes after TEVR: a risk scoring
system for everyday use
I. Loftus (London/UK)
1002.3 What recent developments help us to treat disease
in the ascending aorta and aortic arch?
M.D. Dake (Stanford, CA/US)
1002.4 What is the current role of branched endografts in
thoracoabdominal aneurysms and dissections?
E.L. Verhoeven (Nuremberg/DE)
10:00-11:00
Irreversible electroporation – true revolution?
10:00-11:00
Renal denervation
10:00-11:00
Radiation protection for patients and staff
in interventional procedures
1003.1 How you can develop this procedure
in your hospital
A.-M. Belli (London/UK)
1003.2 How do I decide between all of the devices
and techniques?
M.R. Sapoval (Paris/FR)
1003.3 Complications and their management
P. Reimer (Karlsruhe/DE)
1003.4 What is the evidence for efficacy?
1005.1 Status of technology
T.K. Helmberger (Munich/DE)
1005.2 Liver applications
L. Crocetti (Pisa/IT)
1005.3 Pancreatic applications
G. Narayanan (Miami, FL/US)
1005.4 Imaging after irreversible electroporation
M. Abdel Rehim (Clichy-Paris/FR)
1006.1 R.D. Silkoset (Østerås/NO)
1006.2 A. Widmark (Østerås/NO)
10:30-12:30
VAT-HoW 1 Hands-on Workshop
Vertebral augmentation techniques /
vertebroplasty
Coordinators: J. Garnon (Strasbourg/FR),
11:15-12:45
RD-HoW 1 Hands-on Workshop
Renal denervation
Coordinators: F. Fanelli (Rome/IT),
G.S. Goh (London/UK)
C RSE
Barcelona 2013
11:30-12:30
Spine interventions: how I do it
1101.1 Spinal approach and bone biopsy
R.-T. Hoffmann (Dresden/DE)
1101.2 Vertebroplasty
1101.3 Balloon augmentation/stentoplasty
1101.4 Facet joints and discs
D.K. Filippiadis (Athens/GR)
11:30-12:30
Embolization in the thorax
11:30-12:30
Evidence forum:
SFA – do we know the optimal treatment yet?
1102.1 Bare metallic stents
P.A. Gaines (Sheffield/UK)
1102.3 Stent-grafts
M. Schoder (Vienna/AT)
G. Tepe (Rosenheim/DE)
1102.5 Atherectomy, cutting balloons
M.S. Hamady (London/UK)
1102.6 Summary of evidence and panel discussion
11:30-12:30
Controversies in portal hypertension
1103.1 TIPS should be primary therapy for
refractory ascites: Pro
J.I. Bilbao (Pamplona/ES)
1103.2 TIPS should be primary therapy for
refractory ascites: Con
J.C. García-Pagán (Barcelona/ES)
1103.3 TIPS should be primary therapy for severe
variceal haemorrhage: Pro
G.M. Richter (Stuttgart/DE)
1103.4 TIPS should be primary therapy for severe
variceal haemorrhage: Con
P.E. Huppert (Darmstadt/DE)
1103.5 Gastric variceal haemorrhage after failed
endoscopic therapy: BRTO
S. Hirota (Nishinomiya/JP)
1103.6 Gastric variceal haemorrhage after failed
endoscopic therapy: TIPS
Z.J. Haskal (Baltimore, MD/US)
1104.1 Modern imaging strategy for haemoptysis
A.M. Madureira (Porto/PT)
1104.2 Basic and advanced techniques for bronchial
artery embolization
F. Wolf (Vienna/AT)
1104.3 How to treat pulmonary artery aneurysms and
vascular malformations
J.A. Vos (Nieuwegein/NL)
1104.4 Blunt and penetrating trauma
P. Minko (Homburg/DE)
11:30-12:30
Combined treatments in liver cancer
1105.1 L. Hechelhammer (St. Gallen/CH)
1105.2 A.N. Chatziioannou (Athens/GR)
11:30-12:30
Radiation dose management
1106.1 Understanding pros and cons of the new X-ray
systems in improvement of radiation safety and
image quality
E. Vano (Madrid/ES)
1106.2 What is the real risk of radiation-induced cataracts
for interventionists?
M. Bezzi (Rome/IT)
1106.3 Hybrid rooms for IR: how to plan a good radiation
safety programme
G.N. Paulo (Coimbra/PT)
1106.4 Efficient dose management as a result of
preplanning image-guided IR procedures
G. Bartal (Kfar-Saba/IL)
12:45-14:15
IVC filters
37
38
12:45-14:15
Tumour ablation: tips and tricks / liver
16:15-17:15
Free Papers
17:00-18:30
13:00-14:00
Satellite Symposia
14:30-16:00
Andreas Gruentzig Lecture /
Hot Topic Symposium
17:30-18:30
WS 1501 Workshop
Advanced aortoiliac interventions:
HL 1301 Andreas Gruentzig Lecture
1301.1 EVAR for AAA – evolution or revolution?
A. Holden (Auckland/NZ)
HTS 1302 Intra-arterial stroke management –
should this be an IR procedure?
1302.1 Recent developments regarding the training of
neuroradiologists and other specialties for
neurointerventions
1302.2 Intra-arterial thrombectomy should only be
performed by dedicated neuroradiologists
T. Andersson (Stockholm/SE)
1302.3 Intra-arterial thrombectomy can be safely perform
ed by a well trained “general interventionalist”
1302.4 How much are general IRs involved in stroke
therapy across Europe?
1302.5 A plan for the future involvement of IRs in the
provision of acute stroke therapy
14:30-15:30
Satellite Symposia
16:00-17:30
EMT-HoW 1 Hands-on Workshop
Embolization: materials and tools / coils & plugs
Coordinators: S.J. McPherson (Leeds/UK),
E.M. Walser (Galveston, TX/US)
16:00-17:30
bone and soft tissue
1501.1 M.B. Matson (London/UK)
1501.2 D.K. Tsetis (Iraklion/GR)
17:30-18:30
WS 1502 Workshop
IVC filters: what you need to know
1502.1 M.F. Given (Dublin/IE)
1502.2 A.F. Watkinson (Exeter/UK)
17:30-18:30
WS 1503 Workshop
GI haemorrhage: case-based discussions
1503.1 F. Melchiorre (Milan/IT)
1503.2 C.E. Ray (Golden, CO/US)
17:30-18:30
WS 1504 Workshop
Acute pancreatitis: case-based discussions
1504.1 E.M. Walser (Galveston, TX/US)
1504.2 V. Válek (Brno/CZ)
17:30-18:30
WS 1505 Workshop
How I do renal tumour ablation:
RFA and cryotherapy
1505.1 A. Veltri (Orbassano/IT)
1505.2 J. Garnon (Strasbourg/FR)
17:30-18:30
WS 1506 Workshop
How to treat epistaxis: case-based discussions
1506.1 A.D. Platts (London/UK)
1506.2 A.M. Al-Kutoubi (Beirut/LB)
17:30-18:30
Satellite Symposia
Barcelona 2013
08:00-08:20
Satellite Symposia
08:30-09:30
Biliary interventions: how I do it
1701.1 Biliary stenting and drainage
B.S. Tan (Singapore/SG)
1701.2 Manage benign biliary strictures and stones
M. Ryan (Dublin/IE)
1701.3 Percutaneous cholecystostomy
A. Sibert (Clichy/FR)
1701.4 Manage complications of biliary and
gall bladder interventions
D.F. Martin (Manchester/UK)
08:30-09:30
Evidence forum:
BTK – do we know the optimal treatment yet?
1702.1 PTA
J.H. Peregrin (Prague/CZ)
1702.2 Bare stents
M. Di Primio (Paris/FR)
T.W.I. Clark (Philadelphia, PA/US)
1702.5 Stem cell and gene therapy
S. Sharma (Delhi/IN)
1702.6 Summary of evidence and panel discussion
08:30-09:30
Carotid and vertebral artery intervention
1703.1 Current optimal imaging strategy for the assessment and follow-up before and after carotid
intervention
1703.2 Stenting vs. endarterectomy vs. medical therapy
trials update
P.R. Taylor (London/UK)
1703.3 Which patients benefit from vertebral
artery intervention?
1703.4 Techniques and outcomes of vertebral
artery angioplasty/stenting
P. Haage (Wuppertal/DE)
08:30-09:30
Haemorrhage
1704.1 G.A. Maleux (Leuven/BE)
1704.2 E. Atar (Petah Tikva/IL)
08:30-09:30
Treatment synergies in liver tumours
1705.1 TACE and systemic treatment in HCC
J.-F.H. Geschwind (Baltimore, MD/US)
1705.2 Thermal ablation and TACE in the treatment of HCC
R. Lencioni (Pisa/IT)
1705.3 Intra-arterial and systemic treatments in
colorectal metastases
to be announced
1705.4 Optimal sequence of ablation and chemotherapy
in colorectal metastases
A. Gillams (London/UK)
08:30-13:00
skills training / emergency EVAR: assessment
and deployment
PTP 3.1 Group 7 (08:30-10:40)
PTP 3.2 Group 8 (09:40-11:50)
PTP 3.3 Group 9 (10:50-13:00)
10:00-11:00
Biopsy and abscess drainage: how I do it
1801.1 Lung and mediastinal biopsy
T. Sabharwal (London/UK)
1801.2 Abdominal and pelvic biopsy
M. Düx (Frankfurt/DE)
1801.3 Empyema, lung abscess and mediastinal drainage
1801.4 Abdominal and pelvic abscess drainage
P.R. Mueller (Boston, MA/US)
39
40
10:00-11:00
Evidence forum:
Which treatment should we use? – 3cm HCC
10:00-11:00
Controversies in aortic intervention
1802.1 Chimneys and periscopes can replace fenestrated
and branched endografts: Pro
J. Hardman (Bath/UK)
1802.2 Chimneys and periscopes can replace fenestrated
and branched endografts: Con
M.A. Funovics (Vienna/AT)
1802.3 Multilayered stents have a role in aortic
aneurysm: Pro
M.A. Ruffino (Turin/IT)
1802.4 Multilayered stents have a role in aortic
aneurysm: Con
T. Rand (Vienna/AT)
1802.5 Evidence supports TEVR in patients with
uncomplicated acute type B dissection: Pro
J.-P. Beregi (Nîmes/FR)
1802.6 Evidence supports TEVR in patients with
uncomplicated acute type B dissection: Con
P.R. Taylor (London/UK)
10:00-11:00
Varicose veins
1805.1 Surgery
J. Fuster Obregón (Barcelona/ES)
1805.2 Alcohol
K. Malagari (Athens/GR)
1805.3 RFA
L. Bianchi Cardona (Barcelona/ES)
1805.4 Microwave
M. Kuang (Guangzhou/CN)
1805.5 TACE and drug-eluting beads
Y. Arai (Tokyo/JP)
1805.6 Irreversible electroporation
G. Narayanan (Miami, FL/US)
1805.7 Moderator’s summary and discussion
10:30-12:30
vertebroplasty & kyphoplasty
1803.1 Which patients should we treat?
J.A. Kaufman (Portland, OR/US)
1803.2 Endothermal vein ablation: step by step
1803.3 What other endovenous techniques can we use?
1803.4 How can IRs set up a varicose vein
ablation service?
D.J. West (Stoke-on-Trent/UK)
11:15-12:45
Embolization: materials and tools /
coils & plugs
11:15-12:45
Renal denervation
10:00-11:00
Visceral artery aneurysms
1804.1 Epidemiology and indications for treatment
F. Thony (Grenoble/FR)
1804.2 How should we treat aneurysms of the main SMA
or the celiac trunk?
L.P. Lawler (Dublin/IE)
1804.3 How should we treat aneurysms involving the
pancreaticoduodenal arcade?
P.P. Goffette (Brussels/BE)
1804.4 Is there a role for flow diverting stents?
F. Fanelli (Rome/IT)
11:30-12:30
Satellite Symposia
12:45-14:15
IVC filters
C RSE
Barcelona 2013
12:45-14:15
Tumour ablation: tips and tricks / lung
18:00-19:00
WS 2301 Workshop
Advanced endoleak management
2301.1
R.G. McWilliams (Liverpool/UK)
2301.2 F. Pozzi-Mucelli (Trieste/IT)
13:00-14:00
Satellite Symposia
18:00-19:00
WS 2302 Workshop
Interventions for chylothorax and
chylous ascites
13:00-14:30
General Assembly
14:15-15:15
Satellite Symposia
15:30-16:30
FI 2101 Film Interpretation Quiz
Coordinators:
S. Macdonald (Newcastle-upon-Tyne/UK),
O.M. van Delden (Amstderdam/NL)
16:00-17:30
liquid agents
16:30-18:00
ST-HoW 1 Hands-on Workshop
Stroke therapy
Coordinators: J. Berkefeld (Frankfurt/DE),
16:45-17:45
Free Papers
2302.1 S.M. Lyon (Melbourne, VIC/AU)
2302.2 M. Itkin (Philadelphia, PA/US)
18:00-19:00
WS 2303 Workshop
How to start your vascular
malformation practice
2303.1 L.J. Schultze Kool (Nijmegen/NL)
2303.2 Y.-S. Do (Seoul/KR)
18:00-19:00
WS 2304 Workshop
Metastatic bone disease – embolization,
cementoplasty and ablation:
2304.1 A. Manca (Candiolo/IT)
2304.2 S. Masala (Rome/IT)
18:00-19:00
WS 2305 Workshop
Musculoskeletal ultrasound-guided
procedures
2305.1 P. Peetrons (Brussels/BE)
2305.2 H. Guerini (Paris/FR)
17:00-18:30
18:00-19:00
WS 2306 Workshop
Palliation in interventional oncology
(pleural effusions, ascites, pain, etc)
2306.1 E. Alexopoulou (Athens/GR)
2306.2 G.J. Munneke (London/UK)
18:00-19:00
Satellite Symposia
41
42
08:30-09:30
Ischaemic stroke management –
problems and solutions
08:00-08:20
Satellite Symposia
08:30-09:30
New platforms/agents for drug delivery
2501.1 Thermally sensitive doxorubicin carriers
R. Lencioni (Pisa/IT)
2501.2 Chemosaturation
B.J. Wood (Bethesda, MD/US)
2501.3 HIFU-assisted drug delivery
A. Melzer (Dundee/UK)
2501.4 Percutaneous intratumoural viral therapy
S.C. Rose (San Diego, CA/US)
08:30-10:00
V V-HoW 2 Hands-on Workshop
Varicose veins
08:30-13:00
skills training / emergency embolization:
trauma and other haemorrhagic emergencies
08:30-09:30
Surveillance after aortic endografting
2502.1 Optimal imaging strategy post EVAR
R. Iezzi (Rome/IT)
2502.2 Predicting reintervention rates after EVAR for AAA:
do all patients need the same surveillance?
M. Thompson (London/UK)
2502.3 Do we need plain abdominal radiographs post EVAR?
R.G. McWilliams (Liverpool/UK)
2502.4 Post TEVR – does everybody need CTA forever?
G. Rosen (Tel Aviv/IL)
08:30-09:30
Trauma
2503.1 Renal trauma
S. Park (Daejeon/KR)
2503.2 Mesenteric and hepatic vascular trauma
2503.3 Supra-aortic arterial trauma
P.K. Ellis (Belfast/UK)
2503.4 Lower extremity arterial trauma
C. De Vries (Bloemfontein/ZA)
08:30-09:30
Acute and chronic low back pain
2504.1 A.D. Kelekis (Athens/GR)
2504.2 W.A. Clark (Kogarah, NSW/AU)
2505.1 T. Andersson (Stockholm/SE)
2505.2 T. Liebig (Köln/DE)
PTP 4.1 Group 10 (08:30-10:40)
PTP 4.2 Group 11 (09:40-11:50)
PTP 4.3 Group 12 (10:50-13:00)
10:00-11:00
Evidence forum:
Which treatment should we use? –
Colorectal liver metastases
2601.1 Surgery
S. López-Ben (Girona/ES)
2601.2 RFA
A. Gillams (London/UK)
2601.3 Microwave
L. Solbiati (Busto Arsizio/IT)
2601.4 TACE and drug-eluting beads
F. Orsi (Milan/IT)
2601.5 Radioembolization
R. Salem (Chicago, IL/US)
2601.6 Intra-arterial chemotherapy
2601.7 Irreversible electroporation
M.E. Hicks (Houston, TX/US)
2601.8 Moderator’s summary and discussion
C RSE
Barcelona 2013
10:00-11:00
Controversies in endoleak management
10:30-12:30
vertebroplasty & stentoplasty
2602.1 There is sufficient evidence to treat type 2
endoleaks post EVAR: Pro
M. Černá (Olomouc/CZ)
2602.2 There is sufficient evidence to treat type 2
endoleaks post EVAR: Con
2602.3 EVAR: Type 2 endoleaks should be treated by
direct sac puncture embolization
H. Kobeiter (Créteil/FR)
2602.4 EVAR: Type 2 endoleaks should be treated by
transarterial embolization
K. Schürmann (Dortmund/DE)
2602.5 TEVR: Type 2 endoleaks require treatment: Pro
J.C. van den Berg (Lugano/CH)
2602.6 TEVR: Type 2 endoleaks require treatment: Con
M. Thompson (London/UK)
10:00-11:00
Acute deep venous thrombosis
11:15-12:45
Renal denervation
11:15-12:45
Embolization: materials and tools / liquid agents
11:30-12:30
Satellite Symposia
2603.1 Lower limb DVT – which patients should we treat
and how?
H.-J. Wagner (Berlin/DE)
2603.2 Upper limb DVT – which patients should we treat
and how?
V. Bérczi (Budapest/HU)
2603.3 What is the true benefit of thrombectomy devices
in acute upper and lower limb DVT?
M. Rodière (Grenoble/FR)
2603.4 Is there a role for lysis and IVC filters in paediatric DVT?
S. Sierre (Buenos Aires/AR)
13:00-14:30
Josef Roesch Lecture / Hot Topic Symposium
10:00-11:00
Biliary obstruction and acute pancreatitis
2604.1 A. Keeling (Dublin/IE)
2604.2 A.R. van Erkel (Leiden/NL)
10:00-11:00
CM 2605 CIRSE Meets
CIRSE meets Singapore
HL 2801 Josef Roesch Lecture
2801.1 High-intensity focused ultrasound: an IR tool
for the future?
M. Bezzi (Rome/IT)
HTS 2802 Treatment of lung cancer –
the choices, and how to make them
2802.1 The role of imaging in guiding the treatment of
lung cancer
J. Vilar (Valencia/ES)
2802.2 Thermal ablation: research or mainstream therapy?
2802.3 Percutaneous cryotherapy in the lungs and the
thoracic wall
2802.4 Radiation therapy: the oncologist’s view of how to
choose whether and how to treat
L.M. Kenny (Brisbane, QLD/AU)
Moderators: K.-H. Tay (Singapore/SG), M.J. Lee (Dublin/IE)
2605.1 IR management of ultra-large hepatocellular carcinomas
U. Pua (Singapore/SG)
2605.2 Haemodialysis access interventions –
randomised trials from Singapore
F.G. Irani (Singapore/SG)
2605.3 “Angioplasty first” approach to critical limb ischaemia
A. Gogna (Singapore/SG)
14:45-16:15
ST-HoW 2 Hands-on Workshop
Stroke therapy
43
44
14:45-16:15
Tumour ablation: tips and tricks / kidney
15:00-16:00
Satellite Symposia
16:00-17:30
particulate agents
16:15-17:15
AI 3001 Amazing Interventions
16:15-17:15
Clinical practice – lower limb
3002.1 How can IRs provide total management of the
patient with PAD?
3002.2 Non-imaging assessment of the patient with PAD:
essentials
H. Alfke (Lüdenscheid/DE)
3002.3 Peri- and postprocedural coagulation management
A.A. Nicholson (Leeds/UK)
3002.4 Can you explain outcome measures in
peripheral interventions?
J. Lammer (Vienna/AT)
16:15-17:15
New horizons in musculoskeletal interventions
3003.1 MR-guided interventions
3003.2 Percutaneous screw fixation of fractures and
imminent fractures
N. Amoretti (Nice/FR)
3003.3 What’s new in tumour management?
G.C. Anselmetti (Turin/IT)
3003.4 Hybrid interventions: surgery and IR
S.M. Tutton (Milwaukee, WI/US)
16:15-17:15
High-intensity focused ultrasound
3004.1 How much ablation do you need in uterine fibroids?
M. Matzko (Dachau/DE)
3004.2 Morphological and anatomical inclusion criteria
for the treatment of painful bone metastases
W.M. Gedroyc (London/UK)
3004.3 Prostate cancer: focal tumour ablation or total
gland ablation?
A. Napoli (Rome/IT)
3004.4 Technical advances for breast tumours
M. van den Bosch (Utrecht/NL)
17:30-18:30
WS 3101 Workshop
TIPS and BRTO: case-based discussions
3101.1 S. Punamiya (Singapore/SG)
3101.2 K. Kichikawa (Nara/JP)
17:30-18:30
WS 3102 Workshop
Advanced dialysis graft and fistula management
3102.1 M. Katoh (Krefeld/DE)
3102.2 S.O. Trerotola (Philadelphia, PA/US)
17:30-18:30
WS 3103 Workshop
Advanced vascular malformation management:
3103.1 P. Waldenberger (Linz/AT)
3103.2 A.M. Cahill (Philadelphia, PA/US)
17:30-18:30
WS 3104 Workshop
Non-vascular renal interventions:
3104.1 M.K. Glynos (Athens/GR)
3104.2 A.G. Ryan (Waterford City/IE)
17:30-18:30
WS 3105 Workshop
Portal vein embolization: what you need to know
3105.1 A. Denys (Lausanne/CH)
3105.2 K.P. van Lienden (Amsterdam/NL)
17:30-18:30
WS 3106 Workshop
ABC of varicose vein ablation
3106.1 L. Oguzkurt (Adana/TR)
3106.2 M. Åkesson (Malmoe/SE)
17:30-18:30
Free Papers
Barcelona 2013
08:30-09:30
WS 3201 Workshop
Acute limb ischaemia: case-based discussions
09:45-10:45
IR after surgical disasters
3201.1 J.M. Pulido-Duque (Las Palmas de Gran Canaria/ES)
3201.2 H.-J. Wagner (Berlin/DE)
08:30-09:30
WS 3202 Workshop
ABC of erectile dysfunction
3202.1 L. Machan (Vancouver, BC/CA)
3202.2 N. McEniff (Dublin/IE)
08:30-09:30
WS 3203 Workshop
How to pass the EBIR
3203.1 K.A. Hausegger (Klagenfurt/AT)
3203.2 R. Uberoi (Oxford/UK)
08:30-09:30
WS 3204 Workshop
Radioembolization: what you need to know
3204.1 T.F. Jakobs (Munich/DE)
3204.2 A. Martínez de la Cuesta (Pamplona/ES)
09:45-10:45
Controversies in vascular intervention
3301.1 BTK occlusion – after a failed antegrade attempt,
transpedal access should be attempted before
fem-distal bypass: Pro
K.N. Katsanos (London/UK)
3301.2 BTK occlusion – after a failed antegrade attempt,
transpedal access should be attempted before
fem-distal bypass: Con
R.J. Hinchliffe (London/UK)
3301.3 Patients with lifestyle limiting claudication should
be treated by exercise therapy before angioplasty:
Pro
M.J.W. Koelemaij (Amsterdam/NL)
3301.4 Patients with lifestyle limiting claudication should
be treated by exercise therapy before angioplasty:
Con
3301.5 There is enough evidence to justify lysis/
thrombectomy for acute iliofemoral DVT: Pro
B. Gebauer (Berlin/DE)
3301.6 There is enough evidence to justify lysis/
thrombectomy for acute iliofemoral DVT: Con
J. Kettenbach (Bern/CH)
3302.1 Complications of bariatric surgery
(weight-loss surgery)
M. Corona (Rome/IT)
3302.2 IR in complications after
laparoscopic cholecystectomy
K. Güven (Istanbul/TR)
3302.3 IR after urologic procedures or
nephron-sparing surgery
P.J. Haslam (Newcastle-upon-Tyne/UK)
3302.4 IR after Whipple’s duodenopancreatectomy
O.M. van Delden (Amsterdam/NL)
09:45-10:45
EVAR and TEVR complications
3303.1 L. Lönn (Copenhagen/DK)
3303.2 H. Rousseau (Toulouse/FR)
09:45-10:45
New clinical applications for
interventional oncologists 2
3304.1 Adrenal tumours
P.A.M.S. Almeida (Viseu/PT)
3304.2 GIST
P.L. Pereira (Heilbronn/DE)
3304.3 Prostate cancer
J.J. Fütterer (Nijmegen/NL)
3304.4 Thyroid tumours
J.H. Baek (Seoul/KR)
11:00-12:30
MM 3401 Morbidity & Mortality Conference
and Closing
Coordinators: M. Krokidis (London/UK),
R. Uberoi (Oxford/UK)
45
46
Hands-on Workshops
Hands-on Workshops
Embolization: materials and tools
Vascular closure devices (VCDs) are commonly utilised to
manage arterial puncture sites after therapeutic arterial
interventions.
This series of hands-on workshops provides an overview of
current embolization materials and techniques.
This hands-on workshop will introduce and discuss VCDs
currently available on the market in a comprehensive and
balanced manner, including indications for use, optimal technique, contraindications as well as potential complications and
their management. Furthermore, many tips and tricks for pro
per use of closure devices during daily practice will be shared
during the hands-on part. The course will be completed by a
dedicated tutorial of the “preclose” technique for closing large
arterial punctures for total percutaneous aortic repair.
By the end of the workshop all participants should be able to
understand the various principles and indications of current de
vices, completed by the opportunity of extensive sample testing.
Learning objectives
– To become familiar with the current available vascular
closure devices for peripheral and aortic interventions
– To understand when and how to successfully use a vascular
closure device
– To know when not to use a vascular closure device and
how to avoid complications
– To gain experience with the “preclose” technique required
for total percutaneous treatment of aortic aneurysms
In each workshop session a brief introduction is followed by
participants rotating around 4 to 6 tabletop demonstrations.
The workshops may be attended as a series or individually.
Participants will engage informally with instructors and try out
various embolic materials on anatomical and flow models.
The emphasis of the sessions is a hands-on practical approach.
Participants can handle and/or perform embolization with
mechanical, liquid or particulate embolic agents (according to
the session). The focus is on those with limited experience with
embolization or those wishing to refresh their knowledge.
Learning objectives
– To understand the basic principle of embolization
– To become familiar with the common embolic agents
– To be able to choose an appropriate embolic agent
– To know how to correctly prepare and deliver the chosen agent
– To understand how to avoid non-target embolization and
other complications
EMT-HoW 1
Coils & plugs
16:00-17:30
EMT-HoW 2
Coils & plugs
11:15-12:45
16:00-17:30
CD-HoW 1
17:00-18:30
EMT-HoW 3
Liquid agents
CD-HoW 2
17:00-18:30
EMT-HoW 4
Liquid agents11:15-12:45
CD-HoW 3
17:00-18:30
EMT-HoW 5
Particulate agents
Please note that participants need to register in advance at an
extra cost of € 75.
16:00-17:30
Barcelona 2013
Hands-on Workshops
IVC filters
Principles to practice:
education and simulation skills training
IVC filters are widely used in Europe. They all have pros
and cons regarding technical features that make them
more or less difficult to retrieve or convert.
The workshop will start with a 15-minute introduction focused
on the technical features of the filters available in the room.
Participants will then have the opportunity to test the filters
on models, with the help of experts who will be on hand. This
workshop is aimed at vascular IRs who perform IVC filter placement and want to learn the specific techniques of filter
extraction and conversion.
Learning objectives
– To learn the basic technical features of IVC filters and be able
to choose an appropriate device
– To practise the step-by-step technique for implantation and
extraction/conversion
– To learn technical tips and tricks
IVC-HoW 1
12:45-14:15
IVC-HoW 2
12:45-14:15
IVC-HoW 3
12:45-14:15
47
Coordinators: D.O. Kessel (Leeds/UK), I. Robertson (Glasgow/UK)
This popular series of workshops uses a round table
discussion format with topic experts to deliver key
knowledge and practical tips followed by practice with
the aid of high fidelity simulators.
Each session is aimed at delegates with a specific level of
experience (core, intermediate or advanced). The round-table
discussions are themed around learning objectives which
relate to a specific clinical or procedural topic.
The delivery of each session is flexible to respond to delegates’
interests, and emphasis is placed on small group teaching allow
ing close interaction with the expert faculty. Equipment and de
vices will be available to demonstrate deployment technique.
PTP-HoW 1
Renal denervation Saturday, September 14
08:30-13:00
PTP-HoW 2
Peripheral vascular 08:30-13:00
disease: getting better
outcomes in limb ischaemia
PTP-HoW 3
Emergency EVAR:
assessment and
deployment
08:30-13:00
PTP-HoW 4
Emergency embolization: 08:30-13:00
trauma and other
haemorrhagic emergencies
48
Hands-on Workshops
NEW
Renal denervation
Stroke therapy
G. Goh (London/UK)
Transcatheter renal denervation is a novel therapy for patients with treatment resistant hypertension, a condition
that leads to a higher risk of major cardiovascular events.
An increasing number of interventional radiologists are
involved in intra-arterial therapy for acute cerebral stroke.
There is increasing evidence that urgent restoration of
cerebral circulation by mechanical thrombectomy is one of
the most important factors determining the fate of
patients with acute ischaemic stroke.
In this workshop an overview of sympathetic nervous system
anatomy, physiology and physiopathology will be followed by
a description of the technical aspects of renal denervation.
During the hands-on part of the course participants will learn
how to use currently available devices in order to become
familiar with the procedure and be able to compare their
characteristics.
Experienced tutors will be present in an informal setting to
discuss technical tips and tricks, getting you ready to start your
renal denervation practice.
Learning objectives
– To understand the disease of treatment-resistant hypertension
and its relationship with the sympathetic nervous system
– To receive the latest research data
– To understand the principles of patient selection
– To learn how to start a practice in renal denervation
– To understand the technical aspects of renal denervation
– To be familiar with the principles and handling of a selection
of devices
RD-HoW 1
11:15-12:45
RD-HoW 2
11:15-12:45
RD-HoW 3
11:15-12:45
In this workshop participants will have the opportunity to test
several devices specifically designed for intracranial throm
bectomy on a flow model under the supervision of well
recognised experts in the field.
Learning objectives
– To introduce the principles of mechanical thrombectomy in
patients with embolic stroke
– To get to a standardised technique in a step-by-step manner
– To become familiar with four typical devices and their
handling
– To get an impression of how it works from training with the
flow model
– To discuss technical and clinical problems with co-ordinators
and instructors
ST-HoW 1
16:30-18:00
ST-HoW 2
14:45-16:15
Hands-on Workshops
Barcelona 2013
49
Tumour ablation: tips and tricks
Learning objectives
– To understand the most appropriate indications for hepatic
tumour ablation according to present guidelines
– To know how to choose the right ablation technique for
each lesion
– To understand the liver contraindications for local
ablation techniques
– To understand how to enhance the efficacy of a specific ab
lation technique by adjuvant techniques and how to minimise
or avoid the most commonly encountered complications
– To get familiar with ultrasound-guided liver ablation
TA-HoW 4
Bone and soft tissue
The hands-on workshop on tumour ablation is one of
the most practical teaching sessions included in the
CIRSE programme.
The workshop provides 6 sessions which include introductory
interactive case discussions and practical training upon the
basic principles of all current ablation systems. The case discussions will highlight indications-contraindications as well as
complications and ways to avoid or minimise them.
Participants will then have the opportunity to get familiar with
the equipment and the procedure itself, to practice ablation
using various systems under the guidance of international
ablation experts and to perform ultrasound-guided ablation
on in vitro models.
By the end of the workshop participants, even those with little
or no experience in tumour ablation, will be familiar with a
range of ablation techniques and be aware of tips and tricks
for safe and efficacious clinical application.
TA-HoW 1
Starting your practice
12:45-14:15
TA-HoW 2
Starting your practice
16:00-17:30
16:00-17:30
Learning objectives
– To understand the most appropriate indications for bone
tumour ablation according to present guidelines as well as to
know how to choose the right ablation technique for
each lesion
– To understand the bone contraindications for local
ablation techniques
– To understand how to enhance the efficacy of a specific ablation technique by adjuvant techniques and how to avoid or
minimise the most commonly encountered complications
– To get familiar with ultrasound-guided soft-tissue ablation
TA-HoW 5
Lung12:45-14:15
Learning objectives
– To understand the most appropriate indications for lung tumour
ablation according to present guidelines as well as to know
how to choose the right ablation technique for the right lesion
– To understand the liver contraindications for local
ablation techniques
– To understand how to enhance the efficacy of a specific ab
lation technique by adjuvant techniques and how to minimise
or avoid the most commonly encountered complications
TA-HoW 6
Kidney14:45-16:15
Learning objectives
– To understand the basic principles of the various ablation
techniques and to get familiar with the technical intricacies
of the various systems
– To understand the importance of an interdisciplinary tumour
board for selecting the most appropriate therapy
– To get familiar with potential technique and patient specific
contraindications and risk factors
– To get familiar with ultrasound-guided ablation
– To understand the most appropriate indications for renal
tumour ablation according to present guidelines as well as
to know how to choose the right ablation technique for
each lesion
– To understand how to enhance the efficacy of a specific ablation technique by adjuvant techniques and how to avoid or
minimise the most commonly encountered complications
– To get familiar with ultrasound-guided renal ablation
TA-HoW 3
Liver12:45-14:15
50
Hands-on Workshops
Varicose veins
Vertebral augmentation techniques
Endovenous treatment of symptomatic varicose veins has
become more and more accepted throughout Europe. In
many countries these treatments are or will be reimbursed
by insurance companies. Interventional radiologists are
well suited to perform these therapies as they have the
required skill-set, which includes patient evaluation, diagnostic duplex ultrasound, venous access under ultrasound
guidance and catheter-based intervention. Unfortunately
many IRs are not yet familiar with the available techniques
and devices.
Percutaneous vertebroplasty is a technique in which
acrylic cement is injected through a needle into a collap
sed or weakened vertebra. This procedure is effective for
treating certain types of painful vertebral compression
fractures and some painful or unstable benign and
malignant vertebral lesions which fail to respond to
conservative therapies.
This hands-on workshop gives an opportunity to gain familiarity with the most commonly used techniques and devices for
endovenous therapy, including the handling of different fibres
and probes and the corresponding generators. Participants will
learn how to best access the vein with ultrasound guidance,
how to apply tumescent anaesthesia and how to use the
appropriate devices. In addition there will be the opportunity
to gain insightful advice from expert users.
Learning objectives
– To learn about the different methods for endovenous therapies
– To obtain practical experience with different devices
– To receive hands-on training in ultrasound-guided
venous access
– To learn the technique of tumescent anaesthesia
VV-HoW 1
08:30-10:00
VV-HoW 2
08:30-10:00
Kyphoplasty is an adaptation of vertebroplasty. High pressure
balloons are inserted into the vertebral bodies and enable the
creation of a cavity into which cement can be safely injected.
Stentoplasty is a further recently developed adaptation which
involves placing two metallic stents (cages) within the collap
sed vertebral body and to expand them. The main goal of
stentoplasty is to restore the vertebral body height before
cementation.
As in past CIRSE congresses, this workshop will give an insight
into the principles and techniques of above-mentioned procedures. It will start with a theoretical introduction and a brief
review of the principles and indications. This will be followed
by a hands-on demonstration. Participants will have the
opportunity to practice needle placement, cement preparation and injection on plastic spine models under fluoroscopic
guidance.
Learning Objectives
– To understand the basic principles of the procedures
– To get familiar with the currently available vertebral
augmentation techniques
– To practise needle placement on a lumbar vertebral body
model under fluoroscopic guidance
– To learn and practise cement preparation and delivery under
fluoroscopic guidance
– To learn how to perform kyphoplasty/stentoplasty
C RSE
Hands-on Workshops
Barcelona 2013
VAT-HoW 1
Vertebroplasty10:30-12:30
VAT-HoW 2
Vertebroplasty 10:30-12:30
& kyphoplasty
VAT-HoW 3
Vertebroplasty 10:30-12:30
& stentoplasty
E d u cation in I nterventional R adiolog y
u
www.esir.org ... Interventional Radiology at your fingertips
Did you know that ESIRonline contains more than 5,800
presentations from all areas of interventional radiology?
CIRSE members benefit from year-round access to the
complete lecture database on ESIRonline.
Barcelona 2013 | Annual Meeting and Postgraduate Course
51
Cardiovascular and Interventional Radiological Society of Europe
ESIR 2013
European School of Interventional Radiology
In 2013, the CIRSE Foundation will organise eight local courses
in different university hospitals around Europe
Course Programme
Stroke Intervention (Level 4/Advanced)
April 12-13, 2013
Klagenfurt / AT
Embolisation (Level 2-3/Intermediate)
April 19-20, 2013
Odense / DK
Biopsies & Drainage Procedures (Level 1/Basic)
May 24-25, 2013
Ankara / TR
Musculoskeletal Interventions (Level 1/Basic)
June 7-8, 2013
Athens / GR
Lung Interventions: Embolisation & Ablation (Level 4/Advanced)
July 5-6, 2013
Frankfurt / DE
Management of Resistant Hypertension:
Renal Artery Denervation (Level 4/Advanced)
October 18-19, 2013
Rome / IT
Tumour Ablation (Level 1/Basic)
November 8-9, 2013
Lausanne / CH
Peripheral Arteries & Lower Extremities (Level 1/Basic)
November 15-16, 2013
Amsterdam / NL
For more information on upcoming ESIR courses,
please contact [email protected]
C RSE
foundation
Barcelona 2013
General Information
General Information
Dates
CIRSE 2013 will take place September 14-18, 2013.
Venue
CCIB
Plaça de Willy Brandt 11-14
08019 Barcelona
Spain
CME Credit Allowance
European Accreditation will be applied for at the EACCME
(European Accreditation Council for Continuing Medical
Education) in order to validate the credits in CIRSE participants’
European home countries. The EACCME is an institution of the
European Union of Medical Specialists (UEMS), www.uems.net.
All CME activities approved by the EACCME are valid for recognition by the American Medical Association (AMA) towards
the Physician‘s Recognition Award (PRA). For details how to
convert EACCME credits to AMA PRA category 1 credits, please
contact the AMA (www.ama-assn.org). Live educational activities occurring outside of Canada and recognised by the UEMSEACCME for ECMEC credits are deemed to be Accredited Group
Learning Activities (Section 1) as defined by the Maintenance
of Certification Program of The Royal College of Physicians and
Surgeons of Canada.
CIRSE 2012 in Lisbon, Portugal, was granted 27 hours of
European external CME credits.
CIRSE Central Office
Neutorgasse 9/6
1010 Vienna
Austria
Phone: +43 1 9042003
Fax: +43 1 9042003 30
E-mail: [email protected]
www.cirse.org
Hotel and Travel Booking
In cooperation with its travel partner Kuoni DMC, CIRSE has
secured a great number of hotel rooms in Barcelona for the
benefit of our congress participants.
Online hotel reservation is now available at www.cirse.org.
If you have any questions, please do not hesitate to contact:
Kuoni Destination Management
Your contact: Ivan Muñoz
Calle Pau Claris, 138, 1a 3a
08009 Barcelona
Spain
Phone: +34 902 060026 or +34 93 5052510
Fax: +34 93 4883703
E-mail: [email protected]
Booking Conditions
Rooms will be allocated on a “first come – first served” basis.
A one night deposit per reserved room is required to secure
your hotel reservation. All payments are requested to be made
in Euro (€). Bank fees will be charged to the participant. Please
note, that your payment must reach Kuoni DMC no later than
10 days after booking, otherwise your reservation will be
cancelled.
Group Requests (10 rooms and more):
For group bookings please send your request directly to
KUONI, Mr Ivan Muñoz under [email protected]
Cancellation Policy
Please note the following cancellation policy which will apply
to all individual hotel bookings:
Cancellations until July 1, 2013:
100% refund less € 25 handling fee
Cancellation between July 2, 2013 and July 31, 2013:
1 night cancellation fee will apply.
Cancellation received from August 1, 2013 onwards:
No refund can be made, 100% cancellation fee will apply
on full stay.
No shows: Your hotel room will be cancelled after first night of
no show and the full amount of your stay will be charged.
• All cancellations and changes are to be addressed to
Kuoni DMC in writing.
• For changes Kuoni DMC reserves the right to charge an
administration fee.
• Please note that accommodation for additional nights is
strictly subject to the hotel’s availability.
• All necessary refunds will be made after the congress.
53
Submit your manuscript
to a global audience!
CVIR
IMPA ‘S NEW
CT FA
CTOR
2.093
CVIR is the official journal of:
Austrian Society of Interventional Radiology (ÖGIR)
Brazilian Society of Interventional Radiology and Endovascular Surgery (SoBRICE)
British Society of Interventional Radiology (BSIR)
Chinese Society of Interventional Radiology (CSIR)
Czech society of Interventional Radiology (CSIR)
Danish Society of Interventional Radiology (DFIR)
Dutch Society of Interventional Radiology (NGIR)
Finnish Society of Interventional Radiology (FSIR)
German Society of Interventional Radiology (DeGIR)
Indian Society of Vascular and Interventional Radiology (ISVIR)
Interventional Radiology Section of the Polish Medical Society of Radiology (PLTR)
Israeli Society of Interventional Radiology (ILSIR)
Japanese Society of Interventional Radiology (JSIR)
Korean Society of Interventional Radiology (KSIR)
Russian Society of Interventional Onco-Radiology (SIOR)
Swiss Society of Cardiovascular and Interventional Radiology (SSCVIR)
Turkish Society of Interventional Radiology (TGRD)
To submit a manuscript, please visit:
http://mc.manuscriptcentral.com/cvr
74 -1551
ISSN 01
00270 •
3-4
35(2) 22
2)
4 4 (201
ogy
l
o
i
d
a
nal R
o
i
t
n
e
ter v
n
I
d
n
lar a
u
c
v o l 3 52
s
a
V
o
i
n o
d
l
Car
apri
12
R
CV
The o
nal
l jour
fficia
Cardi
of the
r
Springe
ovas
terv
and In
cular
entio
di
nal Ra
cie
cal So
ologi
Europ
ty of
20
e
Registration
Barcelona 2013
Congress Registration
Register before June 6, 2013 and benefit from reduced early bird registration fees!
Online registration (secured payment) for CIRSE 2013 is now
available on www.cirse.org. Please note that your registration
must be submitted and all fees paid by the respective deadlines.
Incomplete registrations (not containing full name and address)
cannot be processed.
Reduced registration fees for CIRSE 2013 are only available for
members who have been in good standing during the years
2012 and 2013 (individuals who become CIRSE members in
2013 will be able to benefit from reduced congress fees for the
meeting in 2014).
Registration Fees (€)
Method of payment
Registration fees are to be paid in Euros (€) by:
• Bank Transfer or
• Credit Card (Visa or Eurocard/Mastercard)
Until June 6, 2013
CIRSE Member Non Member
Resident* (CIRSE Member) Resident* (Non Member)
Nurse/Radiographer* (CIRSE Member)
Nurse/Radiographer* (Non Member)
Undergraduate Student**
€420
€720
€ 270
€ 320
€ 190
€3
00
€ 0
Until July 11, 2013
CIRSE Member Non Member Resident* (CIRSE Member) Resident* (Non Member) Nurse/Radiographer* (CIRSE Member) Nurse/Radiographer* (Non Member) Undergraduate Student** € 580
€ 895
€ 455
€ 520
€ 290
€4
00
€ 0
After July 11, 2013
CIRSE Member Non Member Resident* (CIRSE Member) Resident* (Non Member) Nurse/Radiographer* (CIRSE Member) Nurse/Radiographer* (Non Member) Undergraduate Student** € 675
€ 970
€ 475
€ 550
€4
40
€ 550
€ 0
* to be accompanied by a certificate signed by the
Head of Department
** for undergraduate medical students. Students’ registrations
must be accompanied by a certificate or letter from the
university, confirming the undergraduate medical student
status and by a copy of a valid ID.
Cancellation of congress registration
CIRSE offers all participants the possibility of taking out cancellation insurance with our partner “Europäische Reiseversiche
rung” (see www.cirse.org). CIRSE will not provide refunds after
a cancellation of registration. All requests for refund have to be
issued to the „Europäische Reiseversicherung“.
Name changes will be handled as a cancellation and
new registration.
Additional information
All CIRSE 2013 registrants will be able to print out an invoice
of the registration using their personal log-in details at
www.cirse.org.
Invoices will be issued by:
CIRSE Congress Research Education GmbH,
Neutorgasse 9, 1010 Vienna, Austria
Registration fee deemed as VAT exempt based on article 20
of the Spanish VAT Law 37/1992.
Further information on hotel booking and
registration is available at www.cirse.org
55
56
Accommodation
Hotel List CIRSE 2013 Barcelona
Hotel Cat‘ Single (€)
Double (€)
(Double Room Single Use)
1 Le Meridien
2 Majestic
3 Pullman Barcelona Skipper
4 AC Hotel Barcelona Forum
5 Attica 21 Barcelona Mar
6 Ayre Caspe
7 Barcelo Atenea Mar
8 Barcelona Center
9 Barcelona Princess
10 Barcelo Raval
11 Catalonia Catedral
12 Catalonia Plaza Cataluña
13 Catalonia Ramblas
14 Condes de Barcelona
15 Confortel Barcelona
16 Diagonal Zero
17 Front Maritim
18 Gallery
19 H10 Marina
20 HCC St. Moritz
21 Hesperia Del Mar
22 Hilton Diagonal Mar
23 Icaria Barcelona
24 ME Barcelona
25 Murmuri Barcelona
26 NH Calderon
27 NH Podium
28 Novotel Barcelona City
29 Pere IV
30 Pulitzer
31 Euro Hotel Diagonal Port
32 Regina
33 Silken Diagonal
34 Silken Ramblas
35 TRYP Condal Mar
36 Vincci Bit
37 Vincci Maritimo
38 1898
39 Four Points by Sheraton Barcelona Diagonal
40 HCC Montblanc
41 HCC Open
42 Holiday Inn Barcelona 22@
43 NH Diagonal Center
5*
5*
5*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
4*
3*
3*
3*
3*
3*
330
325
230
219
190
174
194
248
210
219
243
190
220
219
193
215
164
273
170
215
189
255
193
254
294
215
187
201
143
240
172
240
204
219
187
211
211
292
149
176
165
118
143
All rates are in Euro (€), per room, per night, including breakfast & taxes.
352
345
255
244
202
184
204
267
232
235
265
210
240
239
209
236
177
296
185
248
206
286
209
296
314
237
204
223
153
260
181
260
219
273
198
233
233
316
157
204
193
118
153
Travel time
public transport
Travel time
taxi
Cost by
taxi (€)
25 min
25 min
15 min
1 min walk
10 min
30 min
15 min
30 min
2 min walk
30 min
20 min
25 min
25 min
25 min
15 min
2 min walk
10 min
30 min
15 min
20 min
15 min
3 min walk
15 min
10 min
25 min
20 min
20 min
15 min
10 min
25 min
15 min
25 min
15 min
25 min
15 min
10 min walk
10 min walk
25 min
15 min
15 min
30 min
10 min
10 min
15 min
15 min
10 min
1 min walk
5 min
15 min
8 min 20 min
2 min walk
20 min
15 min
20 min
20 min
20 min
10 min
2 min walk
8 min 20 min
10 min
20 min
8 min
3 min walk
10 min
5 min
20 min
20 min
15 min
10 min
10 min
20 min
8 min
20 min
10 min
20 min
10 min
5 min 5 min 15 min
10 min
15 min
25 min 8 min
10 min
12
12
7
–
5
12
5
14
–
14
12
14
14
14
7
–
5
15
7
15
5
–
7
5
15
15
12
6
6
15
5
15
6
15
6
4
4
12
6
12
16
5
6
City Map
Barcelona 2013
57
City Map CIRSE 2013 Barcelona
18
25
8
14 2
26 20
41
6
12
13 32
30
1
34 38
40
33
27
28
39
35
24
11
29
10
43
42
36
37
19
15
23
3
5
31 21 7
9 16
22 4
17
CCIB-Centre de Convencions
Internacional de Barcelona
For more detailed information and online hotel booking, please visit www.cirse.org
Additional information
Barcelona tourism tax is not included in the room rates.
The tourism tax is:
€ 2.48 per person per night in a 5* hotel
The tourism tax must be paid directly at the hotel, up to a maximum of 7 nights and 2 guests per room.
Children under 16 are exempt. (Law 5/2012, 20 March, DOGC)

cirse 2013

Transcription

Documents pareils

Interventional Tumor Therapy Minimally Invasive, Maximally Effective

COuRSE DIRECTORS FACuLTy Comprehensive Review Course

Endometriosis-cyst-ethanol-sclerosis-after-ultrasound

Association-between-intestinal-nodules-of-deeply-infiltrating

RAD TF-4

State of the Art - Cemea del Mezzogiorno